compound_id,uniprot_id,compound_name,standard_inchi_key,max_phase,target_pref_name,gene_names,target_class,wildtype_or_mutant,mutation_information,pubmed_id,standard_type,standard_relation,standard_value,standard_units,mode_of_action,assay_format,assay_type,assay_sub_type,inhibitor_type,detection_technology,compound_concentration_value,compound_concentration_value_units,substrate_type,substrate_type_standard_relation,substrate_type_standard_value,substrate_type_standard_units,assay_cell_line,assay_description,activity_comments,title,journal,year,volume,issue,authors,annotation_comments,assay_id,dtc_tid,dtc_activity_id,dtc_molregno,record_id,dtc_document_id,PIC50,Unnamed: 0,CID,smiles,rdkit_smiles
CHEMBL100086,P46098,,OSVMSQACZRYAPT-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,12482441.0,IC50,>,100000.0,NM,,,,,,,,,,,,,,Inhibitory concentration required against 5-HT3 receptor in bovine area postrema using [3H]GR-65630,,Development of a presynaptic 5-HT1A antagonist.,Bioorg. Med. Chem. Lett.,2003.0,13.0,2.0,"Mattson RJ, Catt JD, Sloan CP, Gao Q, Carter RB, Gentile A, Mahle CD, Matos FF, McGovern R, VanderMaelen CP, Yocca FD",,3062.0,DTCT0023221,1489397,DTCC00263953,917398,5847,4.0,0,9845261,COC1=CC=CC(=C1)CN2CCN(CC2)C3CCC(CC3)(C4=CC5=C(C=C4)OCO5)O,COc1cccc(CN2CCN(C3CCC(O)(c4ccc5c(c4)OCO5)CC3)CC2)c1
CHEMBL1082723,P46098,NITD609,CKLPLPZSUQEDRT-WPCRTTGESA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20813948.0,IC50,>,10000.0,NM,,,,,,,,,,,,,,Binding affinity to human recombinant serotonin 5HT3 receptor,,"Spiroindolones, a potent compound class for the treatment of malaria.",Science,2010.0,329.0,5996.0,"Rottmann M, McNamara C, Yeung BK, Lee MC, Zou B, Russell B, Seitz P, Plouffe DM, Dharia NV, Tan J, Cohen SB, Spencer KR, González-Páez GE, Lakshminarayana SB, Goh A, Suwanarusk R, Jegla T, Schmitt EK, Beck HP, Brun R, Nosten F, Renia L, Dartois V, Keller TH, Fidock DA, Winzeler EA, Diagana TT",,658586.0,DTCT0023221,3467863,DTCC00031143,1686650,40818,5.0,4,44469321,CC1CC2=C(C3(N1)C4=C(C=CC(=C4)Cl)NC3=O)NC5=CC(=C(C=C25)F)Cl,CC1Cc2c([nH]c3cc(Cl)c(F)cc23)C2(N1)C(=O)Nc1ccc(Cl)cc12
CHEMBL1083485,P46098,,YOCUJVXRRWEPDN-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20465311.0,IC50,>,30000.0,NM,,cell_based,,,,,,,,,,,HEK293,Agonist activity at human 5HT3A receptor expressed in HEK293 cells by FLIPR assay,,"Novel alpha-7 nicotinic acetylcholine receptor agonists containing a urea moiety: identification and characterization of the potent, selective, and orally efficacious agonist 1-[6-(4-fluorophenyl)pyridin-3-yl]-3-(4-piperidin-1-ylbutyl) urea (SEN34625/WYE-103914).",J. Med. Chem.,2010.0,53.0,11.0,"Ghiron C, Haydar SN, Aschmies S, Bothmann H, Castaldo C, Cocconcelli G, Comery TA, Di L, Dunlop J, Lock T, Kramer A, Kowal D, Jow F, Grauer S, Harrison B, La Rosa S, Maccari L, Marquis KL, Micco I, Nencini A, Quinn J, Robichaud AJ, Roncarati R, Scali C, Terstappen GC, Turlizzi E, Valacchi M, Varrone M, Zanaletti R, Zanelli U",,634700.0,DTCT0023221,3345977,DTCC00645978,1654372,39082,4.522878745280337,5,44611748,C1CCN(CC1)CCCCNC(=O)NC2=CN=C(C=C2)C3=CC=CC=C3F,O=C(NCCCCN1CCCCC1)Nc1ccc(-c2ccccc2F)nc1
CHEMBL1083787,P46098,,LMGUUVWYFJIKCD-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20465311.0,IC50,>,30000.0,NM,,cell_based,,,,,,,,,,,HEK293,Agonist activity at human 5HT3A receptor expressed in HEK293 cells by FLIPR assay,,"Novel alpha-7 nicotinic acetylcholine receptor agonists containing a urea moiety: identification and characterization of the potent, selective, and orally efficacious agonist 1-[6-(4-fluorophenyl)pyridin-3-yl]-3-(4-piperidin-1-ylbutyl) urea (SEN34625/WYE-103914).",J. Med. Chem.,2010.0,53.0,11.0,"Ghiron C, Haydar SN, Aschmies S, Bothmann H, Castaldo C, Cocconcelli G, Comery TA, Di L, Dunlop J, Lock T, Kramer A, Kowal D, Jow F, Grauer S, Harrison B, La Rosa S, Maccari L, Marquis KL, Micco I, Nencini A, Quinn J, Robichaud AJ, Roncarati R, Scali C, Terstappen GC, Turlizzi E, Valacchi M, Varrone M, Zanaletti R, Zanelli U",,634700.0,DTCT0023221,3345978,DTCC00645979,1395966,39082,4.522878745280337,6,44240743,C1CCN(CC1)CCCCNC(=O)NC2=CN=C(C=C2)C3=CC=C(C=C3)F,O=C(NCCCCN1CCCCC1)Nc1ccc(-c2ccc(F)cc2)nc1
CHEMBL1083788,P46098,,DFBQTBNRGSIKHN-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20465311.0,IC50,>,30000.0,NM,,cell_based,,,,,,,,,,,HEK293,Agonist activity at human 5HT3A receptor expressed in HEK293 cells by FLIPR assay,,"Novel alpha-7 nicotinic acetylcholine receptor agonists containing a urea moiety: identification and characterization of the potent, selective, and orally efficacious agonist 1-[6-(4-fluorophenyl)pyridin-3-yl]-3-(4-piperidin-1-ylbutyl) urea (SEN34625/WYE-103914).",J. Med. Chem.,2010.0,53.0,11.0,"Ghiron C, Haydar SN, Aschmies S, Bothmann H, Castaldo C, Cocconcelli G, Comery TA, Di L, Dunlop J, Lock T, Kramer A, Kowal D, Jow F, Grauer S, Harrison B, La Rosa S, Maccari L, Marquis KL, Micco I, Nencini A, Quinn J, Robichaud AJ, Roncarati R, Scali C, Terstappen GC, Turlizzi E, Valacchi M, Varrone M, Zanaletti R, Zanelli U",,634700.0,DTCT0023221,3345979,DTCC00645980,652015,39082,4.522878745280337,7,44611875,C1CCN(CC1)CCCCNC(=O)NC2=CN=C(C=C2)C3=CN=C(C=C3)F,O=C(NCCCCN1CCCCC1)Nc1ccc(-c2ccc(F)nc2)nc1
CHEMBL1084363,P46098,,MMXFWZCBTFHARB-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20465311.0,IC50,>,30000.0,NM,,cell_based,,,,,,,,,,,HEK293,Agonist activity at human 5HT3A receptor expressed in HEK293 cells by FLIPR assay,,"Novel alpha-7 nicotinic acetylcholine receptor agonists containing a urea moiety: identification and characterization of the potent, selective, and orally efficacious agonist 1-[6-(4-fluorophenyl)pyridin-3-yl]-3-(4-piperidin-1-ylbutyl) urea (SEN34625/WYE-103914).",J. Med. Chem.,2010.0,53.0,11.0,"Ghiron C, Haydar SN, Aschmies S, Bothmann H, Castaldo C, Cocconcelli G, Comery TA, Di L, Dunlop J, Lock T, Kramer A, Kowal D, Jow F, Grauer S, Harrison B, La Rosa S, Maccari L, Marquis KL, Micco I, Nencini A, Quinn J, Robichaud AJ, Roncarati R, Scali C, Terstappen GC, Turlizzi E, Valacchi M, Varrone M, Zanaletti R, Zanelli U",,634700.0,DTCT0023221,3345974,DTCC00645913,716354,39082,4.522878745280337,8,46831060,C1CCN(CC1)CCCCNC(=O)NC2=CC=C(C=C2)C3=CC=CC=N3,O=C(NCCCCN1CCCCC1)Nc1ccc(-c2ccccn2)cc1
CHEMBL1084364,P46098,,FWCCJDYYJWWQOS-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20465311.0,IC50,>,30000.0,NM,,cell_based,,,,,,,,,,,HEK293,Agonist activity at human 5HT3A receptor expressed in HEK293 cells by FLIPR assay,,"Novel alpha-7 nicotinic acetylcholine receptor agonists containing a urea moiety: identification and characterization of the potent, selective, and orally efficacious agonist 1-[6-(4-fluorophenyl)pyridin-3-yl]-3-(4-piperidin-1-ylbutyl) urea (SEN34625/WYE-103914).",J. Med. Chem.,2010.0,53.0,11.0,"Ghiron C, Haydar SN, Aschmies S, Bothmann H, Castaldo C, Cocconcelli G, Comery TA, Di L, Dunlop J, Lock T, Kramer A, Kowal D, Jow F, Grauer S, Harrison B, La Rosa S, Maccari L, Marquis KL, Micco I, Nencini A, Quinn J, Robichaud AJ, Roncarati R, Scali C, Terstappen GC, Turlizzi E, Valacchi M, Varrone M, Zanaletti R, Zanelli U",,634700.0,DTCT0023221,3345975,DTCC00645914,1525122,39082,4.522878745280337,9,44611609,C1CCN(CC1)CCCCNC(=O)NC2=CN=C(C=C2)C3=CC=CC=C3,O=C(NCCCCN1CCCCC1)Nc1ccc(-c2ccccc2)nc1
CHEMBL1084365,P46098,,HCBWAWNFHVHMOV-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20465311.0,IC50,>,30000.0,NM,,cell_based,,,,,,,,,,,HEK293,Agonist activity at human 5HT3A receptor expressed in HEK293 cells by FLIPR assay,,"Novel alpha-7 nicotinic acetylcholine receptor agonists containing a urea moiety: identification and characterization of the potent, selective, and orally efficacious agonist 1-[6-(4-fluorophenyl)pyridin-3-yl]-3-(4-piperidin-1-ylbutyl) urea (SEN34625/WYE-103914).",J. Med. Chem.,2010.0,53.0,11.0,"Ghiron C, Haydar SN, Aschmies S, Bothmann H, Castaldo C, Cocconcelli G, Comery TA, Di L, Dunlop J, Lock T, Kramer A, Kowal D, Jow F, Grauer S, Harrison B, La Rosa S, Maccari L, Marquis KL, Micco I, Nencini A, Quinn J, Robichaud AJ, Roncarati R, Scali C, Terstappen GC, Turlizzi E, Valacchi M, Varrone M, Zanaletti R, Zanelli U",,634700.0,DTCT0023221,3345976,DTCC00645915,652014,39082,4.522878745280337,10,44611611,COC1=CC=CC=C1C2=NC=C(C=C2)NC(=O)NCCCCN3CCCCC3,COc1ccccc1-c1ccc(NC(=O)NCCCCN2CCCCC2)cn1
CHEMBL1084631,P46098,,FTPAKCBSUUBRFU-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20465311.0,IC50,=,5800.0,NM,,cell_based,,,,,,,,,,,HEK293,Agonist activity at human 5HT3A receptor expressed in HEK293 cells by FLIPR assay,,"Novel alpha-7 nicotinic acetylcholine receptor agonists containing a urea moiety: identification and characterization of the potent, selective, and orally efficacious agonist 1-[6-(4-fluorophenyl)pyridin-3-yl]-3-(4-piperidin-1-ylbutyl) urea (SEN34625/WYE-103914).",J. Med. Chem.,2010.0,53.0,11.0,"Ghiron C, Haydar SN, Aschmies S, Bothmann H, Castaldo C, Cocconcelli G, Comery TA, Di L, Dunlop J, Lock T, Kramer A, Kowal D, Jow F, Grauer S, Harrison B, La Rosa S, Maccari L, Marquis KL, Micco I, Nencini A, Quinn J, Robichaud AJ, Roncarati R, Scali C, Terstappen GC, Turlizzi E, Valacchi M, Varrone M, Zanaletti R, Zanelli U",,634700.0,DTCT0023221,3345972,DTCC00645911,554947,39082,5.236572006437063,11,46831058,C1CCN(CC1)CCCCNC(=O)NC2=CC=C(C=C2)C3=CC=C(C=C3)F,O=C(NCCCCN1CCCCC1)Nc1ccc(-c2ccc(F)cc2)cc1
CHEMBL1084876,P46098,,UPVXJFQSDLKQRB-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20465311.0,IC50,>,30000.0,NM,,cell_based,,,,,,,,,,,HEK293,Agonist activity at human 5HT3A receptor expressed in HEK293 cells by FLIPR assay,,"Novel alpha-7 nicotinic acetylcholine receptor agonists containing a urea moiety: identification and characterization of the potent, selective, and orally efficacious agonist 1-[6-(4-fluorophenyl)pyridin-3-yl]-3-(4-piperidin-1-ylbutyl) urea (SEN34625/WYE-103914).",J. Med. Chem.,2010.0,53.0,11.0,"Ghiron C, Haydar SN, Aschmies S, Bothmann H, Castaldo C, Cocconcelli G, Comery TA, Di L, Dunlop J, Lock T, Kramer A, Kowal D, Jow F, Grauer S, Harrison B, La Rosa S, Maccari L, Marquis KL, Micco I, Nencini A, Quinn J, Robichaud AJ, Roncarati R, Scali C, Terstappen GC, Turlizzi E, Valacchi M, Varrone M, Zanaletti R, Zanelli U",,634700.0,DTCT0023221,3345973,DTCC00645912,1428308,39082,4.522878745280337,12,46831059,C1CCN(CC1)CCCCNC(=O)NC2=CC=C(C=C2)C3=CN=C(C=C3)F,O=C(NCCCCN1CCCCC1)Nc1ccc(-c2ccc(F)nc2)cc1
CHEMBL1085379,P46098,,OXIAXPOOKVTTDN-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20465311.0,IC50,=,5700.0,NM,,cell_based,,,,,,,,,,,HEK293,Agonist activity at human 5HT3A receptor expressed in HEK293 cells by FLIPR assay,,"Novel alpha-7 nicotinic acetylcholine receptor agonists containing a urea moiety: identification and characterization of the potent, selective, and orally efficacious agonist 1-[6-(4-fluorophenyl)pyridin-3-yl]-3-(4-piperidin-1-ylbutyl) urea (SEN34625/WYE-103914).",J. Med. Chem.,2010.0,53.0,11.0,"Ghiron C, Haydar SN, Aschmies S, Bothmann H, Castaldo C, Cocconcelli G, Comery TA, Di L, Dunlop J, Lock T, Kramer A, Kowal D, Jow F, Grauer S, Harrison B, La Rosa S, Maccari L, Marquis KL, Micco I, Nencini A, Quinn J, Robichaud AJ, Roncarati R, Scali C, Terstappen GC, Turlizzi E, Valacchi M, Varrone M, Zanaletti R, Zanelli U",,634700.0,DTCT0023221,3345971,DTCC00645849,1492825,39082,5.2441251443275085,13,46831057,C1CCN(CC1)CCCCNC(=O)NC2=CC=C(C=C2)C3=CC=CC=C3F,O=C(NCCCCN1CCCCC1)Nc1ccc(-c2ccccc2F)cc1
CHEMBL1086332,P46098,,MUIUUGJVKFYPIF-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20465311.0,IC50,=,7900.0,NM,,cell_based,,,,,,,,,,,HEK293,Agonist activity at human 5HT3A receptor expressed in HEK293 cells by FLIPR assay,,"Novel alpha-7 nicotinic acetylcholine receptor agonists containing a urea moiety: identification and characterization of the potent, selective, and orally efficacious agonist 1-[6-(4-fluorophenyl)pyridin-3-yl]-3-(4-piperidin-1-ylbutyl) urea (SEN34625/WYE-103914).",J. Med. Chem.,2010.0,53.0,11.0,"Ghiron C, Haydar SN, Aschmies S, Bothmann H, Castaldo C, Cocconcelli G, Comery TA, Di L, Dunlop J, Lock T, Kramer A, Kowal D, Jow F, Grauer S, Harrison B, La Rosa S, Maccari L, Marquis KL, Micco I, Nencini A, Quinn J, Robichaud AJ, Roncarati R, Scali C, Terstappen GC, Turlizzi E, Valacchi M, Varrone M, Zanaletti R, Zanelli U",,634700.0,DTCT0023221,3345969,DTCC00645847,587120,39082,5.102372908709558,14,46831055,C1CCN(CC1)CCCCNC(=O)NC2=CC=C(C=C2)C3=CC=CC=C3,O=C(NCCCCN1CCCCC1)Nc1ccc(-c2ccccc2)cc1
CHEMBL1086333,P46098,,HSWHSJUFDDMBTI-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20465311.0,IC50,=,7800.0,NM,,cell_based,,,,,,,,,,,HEK293,Agonist activity at human 5HT3A receptor expressed in HEK293 cells by FLIPR assay,,"Novel alpha-7 nicotinic acetylcholine receptor agonists containing a urea moiety: identification and characterization of the potent, selective, and orally efficacious agonist 1-[6-(4-fluorophenyl)pyridin-3-yl]-3-(4-piperidin-1-ylbutyl) urea (SEN34625/WYE-103914).",J. Med. Chem.,2010.0,53.0,11.0,"Ghiron C, Haydar SN, Aschmies S, Bothmann H, Castaldo C, Cocconcelli G, Comery TA, Di L, Dunlop J, Lock T, Kramer A, Kowal D, Jow F, Grauer S, Harrison B, La Rosa S, Maccari L, Marquis KL, Micco I, Nencini A, Quinn J, Robichaud AJ, Roncarati R, Scali C, Terstappen GC, Turlizzi E, Valacchi M, Varrone M, Zanaletti R, Zanelli U",,634700.0,DTCT0023221,3345970,DTCC00645848,197801,39082,5.107905397309519,15,46831056,COC1=CC=CC=C1C2=CC=C(C=C2)NC(=O)NCCCCN3CCCCC3,COc1ccccc1-c1ccc(NC(=O)NCCCCN2CCCCC2)cc1
CHEMBL1086577,P46098,,SLMFOVKWAUVQPC-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20465311.0,IC50,>,30000.0,NM,,cell_based,,,,,,,,,,,HEK293,Agonist activity at human 5HT3A receptor expressed in HEK293 cells by FLIPR assay,,"Novel alpha-7 nicotinic acetylcholine receptor agonists containing a urea moiety: identification and characterization of the potent, selective, and orally efficacious agonist 1-[6-(4-fluorophenyl)pyridin-3-yl]-3-(4-piperidin-1-ylbutyl) urea (SEN34625/WYE-103914).",J. Med. Chem.,2010.0,53.0,11.0,"Ghiron C, Haydar SN, Aschmies S, Bothmann H, Castaldo C, Cocconcelli G, Comery TA, Di L, Dunlop J, Lock T, Kramer A, Kowal D, Jow F, Grauer S, Harrison B, La Rosa S, Maccari L, Marquis KL, Micco I, Nencini A, Quinn J, Robichaud AJ, Roncarati R, Scali C, Terstappen GC, Turlizzi E, Valacchi M, Varrone M, Zanaletti R, Zanelli U",,634700.0,DTCT0023221,3345980,DTCC00645981,1330901,39082,4.522878745280337,16,46831061,C1CCN(CC1)CCCCNC(=O)NC2=CN=C(C=C2)C3=CC=CC=N3,O=C(NCCCCN1CCCCC1)Nc1ccc(-c2ccccn2)nc1
CHEMBL1163015,P46098,,HFOUMBDMIJJHCK-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19700325.0,IC50,=,2800.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human recombinant 5-HT3 receptor expressed in HEK293 cells,,mu-Opioid/5-HT4 dual pharmacologically active agents-efforts towards an effective opioid analgesic with less GI and respiratory side effects (Part I).,Bioorg. Med. Chem. Lett.,2009.0,19.0,19.0,"Shao L, Wang F, Hewitt MC, Barberich TJ",,598654.0,DTCT0023221,3114452,DTCC00650396,1232455,36218,5.552841968657781,23,46906000,CN(CCNC(=O)C1=CC(=C(C=C1OC)N)Cl)CC2CCCCC2(C3=CC(=CC=C3)O)O,COc1cc(N)c(Cl)cc1C(=O)NCCN(C)CC1CCCCC1(O)c1cccc(O)c1
CHEMBL1178,P46098,,UIJIQXGRFSPYQW-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22589534.0,IC50,=,100000.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14720913,DTCC00292803,2102127,68163,4.0,30,5778,CSC1=NC=NC2=C1NC=N2,CSc1ncnc2nc[nH]c12
CHEMBL1189679,P46098,PALONOSETRON,CPZBLNMUGSZIPR-NVXWUHKLSA-N,4,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,24128813.0,IC50,=,0.83,NM,,cell_based,,,,,,,,,,,,Antagonist activity at human wild type 5-HT3A receptor expressed in HEK293 cells assessed as inhibition of 5-HT-induced response after 45 mins by FLIPR assay,,Exploring a potential palonosetron allosteric binding site in the 5-HT(3) receptor.,Bioorg. Med. Chem.,2013.0,21.0,23.0,"Del Cadia M, De Rienzo F, Weston DA, Thompson AJ, Menziani MC, Lummis SC",,1278336.0,DTCT0023221,12951310,DTCC00668368,1419159,56549,9.080921907623926,32,6337614,C1CC2CN(C(=O)C3=CC=CC(=C23)C1)C4CN5CCC4CC5,O=C1c2cccc3c2C(CCC3)CN1C1CN2CCC1CC2
CHEMBL120055,P46098,,DWSOZYFSYVOVOC-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,,IC50,>,10000.0,NM,,,,,,,,,,,,,,Compound was tested for its affinity towards 5-hydroxytryptamine 3 receptor,,,Bioorg. Med. Chem. Lett.,1995.0,5.0,7.0,,,3460.0,DTCT0023221,875262,DTCC00296622,109540,1553,5.0,33,10385855,CC1=CC=CC=C1N2CCN(CC2)C(=O)COC3=CC4=C(C=C3)NC=C4CCN,Cc1ccccc1N1CCN(C(=O)COc2ccc3[nH]cc(CCN)c3c2)CC1
CHEMBL1210154,P46098,,CQUWKHKELQQYRI-KGENOOAVSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20591666.0,IC50,>,10000.0,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]BRL 43694 from human recombinant 5HT3 receptor expressed in CHO cells,,A new group of oxime carbamates as reversible inhibitors of fatty acid amide hydrolase.,Bioorg. Med. Chem. Lett.,2010.0,20.0,15.0,"Gattinoni S, Simone CD, Dallavalle S, Fezza F, Nannei R, Battista N, Minetti P, Quattrociocchi G, Caprioli A, Borsini F, Cabri W, Penco S, Merlini L, Maccarrone M",,643635.0,DTCT0023221,3413129,DTCC00686944,241890,39814,5.0,36,44469677,CC(=NOC(=O)NC1=CC=CC=C1)C2=CC=CC(=C2)C3=CC=CS3,CC(=NOC(=O)Nc1ccccc1)c1cccc(-c2cccs2)c1
CHEMBL1210515,P46098,,RPQHJWKLRRXKIS-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20591663.0,IC50,=,7943.28,NM,,,,,,,,,,,,,,Antagonist activity at human 5HT3 receptor,,Identification of novel alpha7 nAChR positive allosteric modulators with the use of pharmacophore in silico screening methods.,Bioorg. Med. Chem. Lett.,2010.0,20.0,15.0,"Capelli AM, Castelletti L, Salvagno C, Oliosi B, Di Lenarda E, Virginio C, Lightfoot A, Kew JN, Teague S",,643571.0,DTCT0023221,3412864,DTCC00687304,1557285,35708,5.100000128334196,37,49863118,C1CCC(CC1)C2=NN(C(=O)C(=C2)CC3=CC=CO3)CC(=O)NC4CC5=CC=CC=C5C4,O=C(Cn1nc(C2CCCCC2)cc(Cc2ccco2)c1=O)NC1Cc2ccccc2C1
CHEMBL1210703,P46098,,AJTVQZWUKUPHIP-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20591663.0,IC50,=,1000.0,NM,,,,,,,,,,,,,,Antagonist activity at human 5HT3 receptor,,Identification of novel alpha7 nAChR positive allosteric modulators with the use of pharmacophore in silico screening methods.,Bioorg. Med. Chem. Lett.,2010.0,20.0,15.0,"Capelli AM, Castelletti L, Salvagno C, Oliosi B, Di Lenarda E, Virginio C, Lightfoot A, Kew JN, Teague S",,643571.0,DTCT0023221,3412900,DTCC00687492,328485,35708,6.0,38,7446712,CC1=CC(=C(C=C1)NC(=O)C2=CC(=C(S2)N3CCOCC3)C4=CC=CC=C4)C,Cc1ccc(NC(=O)c2cc(-c3ccccc3)c(N3CCOCC3)s2)c(C)c1
CHEMBL1276832,P46098,,VWVPNALHKWLANG-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963.0,IC50,=,48.4,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010.0,53.0,21.0,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849.0,DTCT0023221,3587057,DTCC00706551,1557482,41871,7.315154638355588,65,11190823,CC1=C(SC2=C1C(=O)N(C(=N2)SCCCN3CCN(CC3)C4=NC5=CC=CC=C5C=C4)N)C,Cc1sc2nc(SCCCN3CCN(c4ccc5ccccc5n4)CC3)n(N)c(=O)c2c1C
CHEMBL1276919,P46098,,YURHTDCTHANLFV-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963.0,IC50,>,100.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010.0,53.0,21.0,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849.0,DTCT0023221,3587487,DTCC00706630,133751,41871,7.0,66,23155935,CC1=C(SC2=C1C(=O)N(C(=N2)SCCCN3CCN(CC3)C4=NC5=C(CCCC5)C=C4)N)C,Cc1sc2nc(SCCCN3CCN(c4ccc5c(n4)CCCC5)CC3)n(N)c(=O)c2c1C
CHEMBL1276920,P46098,,YZHWETPHARDZQM-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963.0,IC50,=,87.6,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010.0,53.0,21.0,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849.0,DTCT0023221,3587094,DTCC00706631,619766,41871,7.057495893831919,67,23155946,CC1=C(SC2=C1C(=O)N(C(=N2)SCCCN3CCN(CC3)C4=NC5=CC=CC=C5S4)N)C,Cc1sc2nc(SCCCN3CCN(c4nc5ccccc5s4)CC3)n(N)c(=O)c2c1C
CHEMBL1276921,P46098,,ZNOMCTSKVJJIMN-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963.0,IC50,=,46.5,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010.0,53.0,21.0,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849.0,DTCT0023221,3587054,DTCC00706632,1072234,41871,7.3325470471100465,68,11339853,C1CC2=C(CC1O)C(=O)N(C(=N2)CCCCN3CCN(CC3)C4=NC5=CC=CC=C5C=C4)N,Nn1c(CCCCN2CCN(c3ccc4ccccc4n3)CC2)nc2c(c1=O)CC(O)CC2
CHEMBL1276922,P46098,,MLNBDGCWHJVZAI-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963.0,IC50,=,22.1,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010.0,53.0,21.0,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849.0,DTCT0023221,3587036,DTCC00706633,878675,41871,7.655607726314889,69,49837652,CC(=O)N1CCC2=C(C1)SC3=C2C(=O)N(C(=N3)CCCCN4CCN(CC4)C5=NC6=CC=CC=C6C=C5)N,CC(=O)N1CCc2c(sc3nc(CCCCN4CCN(c5ccc6ccccc6n5)CC4)n(N)c(=O)c23)C1
CHEMBL1277005,P46098,,MPEGWVZSANJAMN-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963.0,IC50,>,100.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010.0,53.0,21.0,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849.0,DTCT0023221,3587474,DTCC00706713,780906,41871,7.0,70,23155950,CC1=C(SC2=C1C(=O)N(C(=N2)SCCCN3CCN(CC3)C4=NC5=CC=CC=C5N=C4C6=CC=CC=C6)N)C,Cc1sc2nc(SCCCN3CCN(c4nc5ccccc5nc4-c4ccccc4)CC3)n(N)c(=O)c2c1C
CHEMBL1277006,P46098,,OHXKHPFEXVDLQZ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963.0,IC50,=,24.6,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010.0,53.0,21.0,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849.0,DTCT0023221,3587039,DTCC00706714,1810952,41871,7.609064892896621,71,23155990,C1CCC2=C(C1)C(=O)N=C(N2)CCCCN3CCN(CC3)C4=NC5=CC=CC=C5C=C4,O=c1nc(CCCCN2CCN(c3ccc4ccccc4n3)CC2)[nH]c2c1CCCC2
CHEMBL1277007,P46098,,QZHACJCMCCGZRU-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963.0,IC50,=,59.1,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010.0,53.0,21.0,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849.0,DTCT0023221,3587069,DTCC00706715,1072235,41871,7.228412519118745,72,23155650,CC1=CC(=NC2=CC=CC=C12)N3CCN(CC3)CCCCC4=NC5=C(CCCC5)C(=O)N4N,Cc1cc(N2CCN(CCCCc3nc4c(c(=O)n3N)CCCC4)CC2)nc2ccccc12
CHEMBL1277098,P46098,,IQKPITCNSNNYNB-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963.0,IC50,>,100.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010.0,53.0,21.0,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849.0,DTCT0023221,3587475,DTCC00706802,684307,41871,7.0,73,23155644,CC1=C(SC2=C1C(=O)N(C(=N2)SCCCN3CCN(CC3)C4=NC5=CC=CC=C5C6=CC=CC=C64)N)C,Cc1sc2nc(SCCCN3CCN(c4nc5ccccc5c5ccccc45)CC3)n(N)c(=O)c2c1C
CHEMBL1277099,P46098,,JIWMRJSKGUAANW-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963.0,IC50,=,41.4,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010.0,53.0,21.0,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849.0,DTCT0023221,3587046,DTCC00706803,133752,41871,7.382999658879101,74,11752512,C1CCC2=C(C1)C3=C(S2)N=C(N(C3=O)N)SCCCN4CCN(CC4)C5=NC6=CC=CC=C6C=C5,Nn1c(SCCCN2CCN(c3ccc4ccccc4n3)CC2)nc2sc3c(c2c1=O)CCCC3
CHEMBL1277100,P46098,,LZVLTVPNYIRFTB-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963.0,IC50,>,100.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010.0,53.0,21.0,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849.0,DTCT0023221,3587488,DTCC00706804,2005627,41871,7.0,75,23155963,CC1=CC2=CC=CC=C2N=C1N3CCN(CC3)CCCCC4=NC5=C(CCCC5)C(=O)N4N,Cc1cc2ccccc2nc1N1CCN(CCCCc2nc3c(c(=O)n2N)CCCC3)CC1
CHEMBL1277101,P46098,,ZRMKLDGEAIPBEE-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963.0,IC50,>,100.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010.0,53.0,21.0,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849.0,DTCT0023221,3587489,DTCC00706805,1331198,41871,7.0,76,23155840,CC1=C(C(=NC2=CC=CC=C12)N3CCN(CC3)CCCCC4=NC5=C(CCCC5)C(=O)N4N)C,Cc1c(N2CCN(CCCCc3nc4c(c(=O)n3N)CCCC4)CC2)nc2ccccc2c1C
CHEMBL1277186,P46098,,DWCWRMNZCYONIV-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963.0,IC50,>,100.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010.0,53.0,21.0,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849.0,DTCT0023221,3587476,DTCC00706886,942829,41871,7.0,77,23155980,CC1=C(SC2=C1C(=O)NC(=N2)SCCCN3CCN(CC3)C4=NC5=CC=CC=C5C=C4)C,Cc1sc2nc(SCCCN3CCN(c4ccc5ccccc5n4)CC3)[nH]c(=O)c2c1C
CHEMBL1277187,P46098,,LLZLRXCVMYYKBH-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963.0,IC50,=,44.2,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010.0,53.0,21.0,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849.0,DTCT0023221,3587051,DTCC00706887,1493079,41871,7.354577730650908,78,23155976,C1CCC2=C(C1)C3=C(S2)N=C(NC3=O)SCCCN4CCN(CC4)C5=NC6=CC=CC=C6C=C5,O=c1[nH]c(SCCCN2CCN(c3ccc4ccccc4n3)CC2)nc2sc3c(c12)CCCC3
CHEMBL1277188,P46098,,VTHVGLORMDHGGF-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963.0,IC50,>,100.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010.0,53.0,21.0,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849.0,DTCT0023221,3587490,DTCC00706888,1039843,41871,7.0,79,23155621,C1CCC2=C(C1)C(=O)N(C(=N2)CCCCN3CCN(CC3)C4=NC5=CC=CC=C5C6=C4CCC6)N,Nn1c(CCCCN2CCN(c3nc4ccccc4c4c3CCC4)CC2)nc2c(c1=O)CCCC2
CHEMBL1277189,P46098,,WOXCQSXEHWXACS-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963.0,IC50,>,100.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010.0,53.0,21.0,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849.0,DTCT0023221,3587491,DTCC00706889,652302,41871,7.0,80,23155885,C1CCC2=C(C1)C3=CC=CC=C3N=C2N4CCN(CC4)CCCCC5=NC6=C(CCCC6)C(=O)N5N,Nn1c(CCCCN2CCN(c3nc4ccccc4c4c3CCCC4)CC2)nc2c(c1=O)CCCC2
CHEMBL1277280,P46098,,HLMKBCUKQMBYDR-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963.0,IC50,=,69.9,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010.0,53.0,21.0,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849.0,DTCT0023221,3587081,DTCC00706972,1460605,41871,7.1555228242543185,81,23155860,C1CN(CCN1CCCSC2=NC3=CC=CC=C3C(=O)N2N)C4=NC5=CC=CC=C5C=C4,Nn1c(SCCCN2CCN(c3ccc4ccccc4n3)CC2)nc2ccccc2c1=O
CHEMBL1277281,P46098,,OJNSMLDRVFFVJN-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963.0,IC50,=,63.8,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010.0,53.0,21.0,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849.0,DTCT0023221,3587076,DTCC00706973,1810956,41871,7.195179321278838,82,23155625,C1CCC2=C(C1)C(=O)N(C(=N2)SCCCN3CCN(CC3)C4=NC5=CC=CC=C5C=C4)N,Nn1c(SCCCN2CCN(c3ccc4ccccc4n3)CC2)nc2c(c1=O)CCCC2
CHEMBL1277282,P46098,,DQFJTXJCMDYWKL-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963.0,IC50,=,52.6,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010.0,53.0,21.0,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849.0,DTCT0023221,3587061,DTCC00706974,942831,41871,7.279014255846261,83,49837758,C1CCC2=C(C1)C(=O)N(C(=N2)CCCCN3CCN(CC3)C4=NC5=CC=CC=C5C=C4O)N,Nn1c(CCCCN2CCN(c3nc4ccccc4cc3O)CC2)nc2c(c1=O)CCCC2
CHEMBL1277283,P46098,,QCJPMOOSRAYGGE-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963.0,IC50,>,100.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010.0,53.0,21.0,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849.0,DTCT0023221,3587492,DTCC00706975,328677,41871,7.0,84,49836152,C1CCC2=C(C1)C(=O)N(C(=N2)CCCCN3CCN(CC3)C4=NC5=C(C=C4)C=C(C=C5)O)N,Nn1c(CCCCN2CCN(c3ccc4cc(O)ccc4n3)CC2)nc2c(c1=O)CCCC2
CHEMBL1277371,P46098,,WCGCGRZZPCFDSO-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963.0,IC50,>,100.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010.0,53.0,21.0,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849.0,DTCT0023221,3587477,DTCC00707056,1428595,41871,7.0,85,23155818,C1CN(CCN1CCCSC2=NC3=C(C=CC(=C3)[N+](=O)[O-])C(=O)N2N)C4=NC5=CC=CC=C5C=C4,Nn1c(SCCCN2CCN(c3ccc4ccccc4n3)CC2)nc2cc([N+](=O)[O-])ccc2c1=O
CHEMBL1277372,P46098,,SPBSBKPLXWUEGQ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963.0,IC50,=,61.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010.0,53.0,21.0,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849.0,DTCT0023221,3587071,DTCC00707057,1200798,41871,7.214670164989233,86,23155951,C1CN(CCN1CCCSC2=NC3=C(C(=O)N2N)N=CC=C3)C4=NC5=CC=CC=C5C=C4,Nn1c(SCCCN2CCN(c3ccc4ccccc4n3)CC2)nc2cccnc2c1=O
CHEMBL1277373,P46098,,UGLUCZYCHYWOCD-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963.0,IC50,=,55.2,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010.0,53.0,21.0,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849.0,DTCT0023221,3587062,DTCC00707058,1525423,41871,7.2580609222708015,87,136002690,C1CCC2=C(C1)C(=O)N(C(=N2)CCCCN3CCN(CC3)C4=NC5=C(C=CC(=C5)O)C=C4)N,Nn1c(CCCCN2CCN(c3ccc4ccc(O)cc4n3)CC2)nc2c(c1=O)CCCC2
CHEMBL1277374,P46098,,HGUUKRWUSHWXTH-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963.0,IC50,=,86.6,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010.0,53.0,21.0,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849.0,DTCT0023221,3587092,DTCC00707059,780910,41871,7.062482107982653,88,49836154,C1CCC2=C(C1)C(=O)N(C(=N2)CN3CCN(CC3)C4=NC5=CC=CC=C5C=C4)N,Nn1c(CN2CCN(c3ccc4ccccc4n3)CC2)nc2c(c1=O)CCCC2
CHEMBL1277462,P46098,,YHOYHBANAWEKNE-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963.0,IC50,=,64.8,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010.0,53.0,21.0,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849.0,DTCT0023221,3587078,DTCC00707139,1493081,41871,7.188424994129407,89,23155948,C1CN(CCN1CCCSC2=NC3=C(C=CC=N3)C(=O)N2N)C4=NC5=CC=CC=C5C=C4,Nn1c(SCCCN2CCN(c3ccc4ccccc4n3)CC2)nc2ncccc2c1=O
CHEMBL1277463,P46098,,MDDLXKDIADSAQA-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963.0,IC50,=,100.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010.0,53.0,21.0,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849.0,DTCT0023221,3587112,DTCC00707140,1200799,41871,7.0,90,11329644,C1CNCC2=C1C3=C(S2)N=C(N(C3=O)N)SCCCN4CCN(CC4)C5=NC6=CC=CC=C6C=C5,Nn1c(SCCCN2CCN(c3ccc4ccccc4n3)CC2)nc2sc3c(c2c1=O)CCNC3
CHEMBL1277464,P46098,,XYQXSKXZFRFXOW-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963.0,IC50,>,100.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010.0,53.0,21.0,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849.0,DTCT0023221,3587493,DTCC00707141,1972994,41871,7.0,91,23155906,C1CCC2=C(C1)C(=O)N(C(=N2)CCN3CCN(CC3)C4=NC5=CC=CC=C5C=C4)N,Nn1c(CCN2CCN(c3ccc4ccccc4n3)CC2)nc2c(c1=O)CCCC2
CHEMBL1277465,P46098,,WCNGVFDLZVYEJL-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963.0,IC50,>,100.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010.0,53.0,21.0,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849.0,DTCT0023221,3587494,DTCC00707142,716655,41871,7.0,92,23155869,C1CCC2=C(C1)C(=O)N(C(=N2)CCCN3CCN(CC3)C4=NC5=CC=CC=C5C=C4)N,Nn1c(CCCN2CCN(c3ccc4ccccc4n3)CC2)nc2c(c1=O)CCCC2
CHEMBL1277558,P46098,,OMACXBJTMXFHCQ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963.0,IC50,=,77.6,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010.0,53.0,21.0,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849.0,DTCT0023221,3587085,DTCC00707232,1331202,41871,7.110138278741812,93,49837354,CC(=O)N1CCC2=C(C1)SC3=C2C(=O)N(C(=N3)SCCCN4CCN(CC4)C5=NC6=CC=CC=C6C=C5)N,CC(=O)N1CCc2c(sc3nc(SCCCN4CCN(c5ccc6ccccc6n5)CC4)n(N)c(=O)c23)C1
CHEMBL1277559,P46098,,FEPROLQKWGDFKU-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963.0,IC50,=,26.7,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010.0,53.0,21.0,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849.0,DTCT0023221,3587040,DTCC00707233,1493086,41871,7.573488738635425,94,11213399,CC1=C(SC2=C1C(=O)N(C(=N2)CCCCN3CCN(CC3)C4=NC5=CC=CC=C5C=C4)N)C,Cc1sc2nc(CCCCN3CCN(c4ccc5ccccc5n4)CC3)n(N)c(=O)c2c1C
CHEMBL1277560,P46098,,OPVPOKBFTBDGTR-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963.0,IC50,>,100.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010.0,53.0,21.0,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849.0,DTCT0023221,3587495,DTCC00707234,684313,41871,7.0,95,23155676,C1CCC2=C(C1)C(=O)N(C(=N2)CCCCCN3CCN(CC3)C4=NC5=CC=CC=C5C=C4)N,Nn1c(CCCCCN2CCN(c3ccc4ccccc4n3)CC2)nc2c(c1=O)CCCC2
CHEMBL1277651,P46098,,GTIKAAJNYPWELX-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963.0,IC50,=,45.7,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010.0,53.0,21.0,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849.0,DTCT0023221,3587053,DTCC00707320,69163,41871,7.34008379993015,96,11464531,C1CN(CCN1CCCCC2=NC3=CC=CC=C3C(=O)N2N)C4=NC5=CC=CC=C5C=C4,Nn1c(CCCCN2CCN(c3ccc4ccccc4n3)CC2)nc2ccccc2c1=O
CHEMBL1277745,P46098,,CFOHOEGJDCNBCR-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963.0,IC50,=,99.4,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010.0,53.0,21.0,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849.0,DTCT0023221,3587110,DTCC00707410,133756,41871,7.002613615602686,97,11305391,C1CN(CCN1CCCCC2=NC3=C(C=C(C=C3)F)C(=O)N2N)C4=NC5=CC=CC=C5C=C4,Nn1c(CCCCN2CCN(c3ccc4ccccc4n3)CC2)nc2ccc(F)cc2c1=O
CHEMBL1277746,P46098,,PWVBQEUMVVPFJT-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963.0,IC50,>,100.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010.0,53.0,21.0,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849.0,DTCT0023221,3587478,DTCC00707411,1810959,41871,7.0,98,23155688,C1CN(CCN1CCCCC2=NC3=C(C=CC(=C3)F)C(=O)N2N)C4=NC5=CC=CC=C5C=C4,Nn1c(CCCCN2CCN(c3ccc4ccccc4n3)CC2)nc2cc(F)ccc2c1=O
CHEMBL1277832,P46098,,ASIIZNZQUBPOJQ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963.0,IC50,>,100.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010.0,53.0,21.0,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849.0,DTCT0023221,3587479,DTCC00707495,1746576,41871,7.0,99,11178730,C1CN(CCN1CCCCC2=NC3=C(C(=CC=C3)Cl)C(=O)N2N)C4=NC5=CC=CC=C5C=C4,Nn1c(CCCCN2CCN(c3ccc4ccccc4n3)CC2)nc2cccc(Cl)c2c1=O
CHEMBL1277833,P46098,,TZSHYDBBXRRBCE-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963.0,IC50,>,100.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010.0,53.0,21.0,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849.0,DTCT0023221,3587480,DTCC00707496,14899,41871,7.0,100,23155955,C1CN(CCN1CCCCC2=NC3=C(C=C(C=C3)Cl)C(=O)N2N)C4=NC5=CC=CC=C5C=C4,Nn1c(CCCCN2CCN(c3ccc4ccccc4n3)CC2)nc2ccc(Cl)cc2c1=O
CHEMBL1277913,P46098,,PYCJRTFNOGPLEL-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963.0,IC50,>,100.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010.0,53.0,21.0,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849.0,DTCT0023221,3587481,DTCC00707572,587403,41871,7.0,101,23155825,C1CN(CCN1CCCCC2=NC3=C(C=CC(=C3)Cl)C(=O)N2N)C4=NC5=CC=CC=C5C=C4,Nn1c(CCCCN2CCN(c3ccc4ccccc4n3)CC2)nc2cc(Cl)ccc2c1=O
CHEMBL1277914,P46098,,XVBPOYYIPRSULQ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963.0,IC50,=,83.1,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010.0,53.0,21.0,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849.0,DTCT0023221,3587089,DTCC00707573,101390,41871,7.080398976215889,102,23155758,C1CN(CCN1CCCCC2=NC3=C(C=CC=C3Cl)C(=O)N2N)C4=NC5=CC=CC=C5C=C4,Nn1c(CCCCN2CCN(c3ccc4ccccc4n3)CC2)nc2c(Cl)cccc2c1=O
CHEMBL1277995,P46098,,RSUQRWJJGYXXCP-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963.0,IC50,>,100.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010.0,53.0,21.0,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849.0,DTCT0023221,3587482,DTCC00707651,1007415,41871,7.0,103,23155900,CC1=C2C(=CC=C1)N=C(N(C2=O)N)CCCCN3CCN(CC3)C4=NC5=CC=CC=C5C=C4,Cc1cccc2nc(CCCCN3CCN(c4ccc5ccccc5n4)CC3)n(N)c(=O)c12
CHEMBL1277996,P46098,,GSEARIWHWZTSPV-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963.0,IC50,=,45.6,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010.0,53.0,21.0,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849.0,DTCT0023221,3587052,DTCC00707652,426610,41871,7.341035157335565,104,11374124,CC1=CC2=C(C=C1)N=C(N(C2=O)N)CCCCN3CCN(CC3)C4=NC5=CC=CC=C5C=C4,Cc1ccc2nc(CCCCN3CCN(c4ccc5ccccc5n4)CC3)n(N)c(=O)c2c1
CHEMBL1278087,P46098,,BSCUUFDNCBQNPG-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963.0,IC50,=,15.6,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010.0,53.0,21.0,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849.0,DTCT0023221,3587028,DTCC00707741,684323,41871,7.806875401645538,105,23155667,CC1=C2C(=CC=C1)C(=O)N(C(=N2)CCCCN3CCN(CC3)C4=NC5=CC=CC=C5C=C4)N,Cc1cccc2c(=O)n(N)c(CCCCN3CCN(c4ccc5ccccc5n4)CC3)nc12
CHEMBL1278088,P46098,,WFQOETMVYMINSA-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963.0,IC50,=,8.9,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010.0,53.0,21.0,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849.0,DTCT0023221,3587017,DTCC00707742,716661,41871,8.050609993355087,106,11430418,C1CCC2=C(C1)C(=O)N(C(=N2)CCCCN3CCN(CC3)C4=NC5=CC=CC=C5C=C4)N,Nn1c(CCCCN2CCN(c3ccc4ccccc4n3)CC2)nc2c(c1=O)CCCC2
CHEMBL1278088,P46098,,WFQOETMVYMINSA-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963.0,IC50,>,8.93,NM,,,,,,,,,,,,,,Displacement of [3H]BRL-43694 from human recombinant 5HT3 receptor,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010.0,53.0,21.0,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684926.0,DTCT0023221,3587018,DTCC00707742,716661,41871,8.049148541111453,106,11430418,C1CCC2=C(C1)C(=O)N(C(=N2)CCCCN3CCN(CC3)C4=NC5=CC=CC=C5C=C4)N,Nn1c(CCCCN2CCN(c3ccc4ccccc4n3)CC2)nc2c(c1=O)CCCC2
CHEMBL1278174,P46098,,HOABLJVFGVOCMM-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963.0,IC50,>,100.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010.0,53.0,21.0,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849.0,DTCT0023221,3587473,DTCC00707823,684327,41871,7.0,107,23155620,CC1=C(SC2=C1C(=O)N(C(=N2)SCCCN3CCN(CC3)C4=CC=CC=N4)N)C,Cc1sc2nc(SCCCN3CCN(c4ccccn4)CC3)n(N)c(=O)c2c1C
CHEMBL1278175,P46098,,GERBCOZLRREKHD-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963.0,IC50,=,48.3,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010.0,53.0,21.0,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849.0,DTCT0023221,3587056,DTCC00707824,2070202,41871,7.316052869248488,108,11476372,CC1CCC2=C(C1)C(=O)N(C(=N2)CCCCN3CCN(CC3)C4=NC5=CC=CC=C5C=C4)N,CC1CCc2nc(CCCCN3CCN(c4ccc5ccccc5n4)CC3)n(N)c(=O)c2C1
CHEMBL1278176,P46098,,FCQFXDREOPQEAF-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20931963.0,IC50,=,97.9,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]BRL-43694 from human 5HT3 receptor expressed in HEK293 cells by liquid scintillation counting,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010.0,53.0,21.0,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684849.0,DTCT0023221,3587109,DTCC00707825,166107,41871,7.009217308196862,109,23155770,CC1CCC2=C(C1)N=C(N(C2=O)N)CCCCN3CCN(CC3)C4=NC5=CC=CC=C5C=C4,CC1CCc2c(nc(CCCCN3CCN(c4ccc5ccccc5n4)CC3)n(N)c2=O)C1
CHEMBL128,P46098,SUMATRIPTAN,KQKPFRSPSRPDEB-UHFFFAOYSA-N,4,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,7752204.0,IC50,>,10000.0,NM,,,,,,,,,,,,,,Binding activity radioligand.,,"Synthesis and serotonergic activity of N,N-dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]ethylamine and analogues: potent agonists for 5-HT1D receptors.",J. Med. Chem.,1995.0,38.0,10.0,"Street LJ, Baker R, Davey WB, Guiblin AR, Jelley RA, Reeve AJ, Routledge H, Sternfeld F, Watt AP, Beer MS",,3126.0,DTCT0023221,520894,DTCC00154636,658692,13017,5.0,110,5358,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C,CNS(=O)(=O)Cc1ccc2[nH]cc(CCN(C)C)c2c1
CHEMBL128,P46098,SUMATRIPTAN,KQKPFRSPSRPDEB-UHFFFAOYSA-N,4,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,9357515.0,IC50,=,9.3,NM,,,,,,,,,,,,,,Compound was evaluated for the affinity at 5-hydroxytryptamine 3 receptor,,"Selective, orally active 5-HT1D receptor agonists as potential antimigraine agents.",J. Med. Chem.,1997.0,40.0,22.0,"MacLeod AM, Street LJ, Reeve AJ, Jelley RA, Sternfeld F, Beer MS, Stanton JA, Watt AP, Rathbone D, Matassa VG",,3459.0,DTCT0023221,712596,DTCC00154636,659675,14385,8.031517051446064,110,5358,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C,CNS(=O)(=O)Cc1ccc2[nH]cc(CCN(C)C)c2c1
CHEMBL1365455,P46098,,MNJNPLVXBISNSX-PBWFPOADSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,26988801.0,IC50,=,6.9,NM,,,,,,,,,,,,,,Displacement of [3H]BRL43694 from human recombinant 5-HT3 receptor expressed in CHO cells,,"Design, physico-chemical properties and biological evaluation of some new N-[(phenoxy)alkyl]- and N-{2-[2-(phenoxy)ethoxy]ethyl}aminoalkanols as anticonvulsant agents.",Bioorg. Med. Chem.,2016.0,24.0,8.0,"Waszkielewicz AM, Gunia-Krzyzak A, Powroznik B, Soczynska K, Pekala E, Walczak M, Bednarski M, Zesawska E, Nitek W, Marona H.",,1559795.0,DTCT0023221,117199,DTCC00772276,517084,66408,8.161150909262744,115,671690,CN1C2CCC1CC(C2)OC(=O)C3=CC(=CC(=C3)Cl)Cl,CN1C2CCC1CC(OC(=O)c1cc(Cl)cc(Cl)c1)C2
CHEMBL1382868,P46098,,BGMSTNYJYPSLHN-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22589534.0,IC50,=,1300.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14713107,DTCC00788480,2098974,68163,5.886056647693163,117,720937,C1=CC=C2C(=C1)C=CC=C2CSC3=NC=NC4=C3NC=N4,c1ccc2c(CSc3ncnc4nc[nH]c34)cccc2c1
CHEMBL138458,P46098,,IJKYJDDNDXAREJ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,11784148.0,IC50,>,10000.0,NM,,,,,,,,,,,,,,Inhibition of GR-65630 binding to 5-hydroxytryptamine 3 receptor,,Novel spiropiperidines as highly potent and subtype selective sigma-receptor ligands. Part 1.,J. Med. Chem.,2002.0,45.0,2.0,"Maier CA, Wünsch B",,3461.0,DTCT0023221,1330607,DTCC00323189,65365,16958,5.0,118,10915140,COC1CC2=CC=CC=C2C3(O1)CCN(CC3)CCCC4=CC=CC=C4,COC1Cc2ccccc2C2(CCN(CCCc3ccccc3)CC2)O1
CHEMBL138809,P46098,,RZZAEVQHACUOGI-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,11784148.0,IC50,>,10000.0,NM,,,,,,,,,,,,,,Inhibition of GR-65630 binding to 5-hydroxytryptamine 3 receptor,,Novel spiropiperidines as highly potent and subtype selective sigma-receptor ligands. Part 1.,J. Med. Chem.,2002.0,45.0,2.0,"Maier CA, Wünsch B",,3461.0,DTCT0023221,1325461,DTCC00323057,1489511,16958,5.0,119,10357986,COC1C2=CC=CC=C2C3(O1)CCN(CC3)CC4=CC=CC=C4,COC1OC2(CCN(Cc3ccccc3)CC2)c2ccccc21
CHEMBL141209,P46098,,POOPPNNSPMKABZ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,11784148.0,IC50,>,10000.0,NM,,,,,,,,,,,,,,Inhibition of GR-65630 binding to 5-hydroxytryptamine 3 receptor,,Novel spiropiperidines as highly potent and subtype selective sigma-receptor ligands. Part 1.,J. Med. Chem.,2002.0,45.0,2.0,"Maier CA, Wünsch B",,3461.0,DTCT0023221,1333323,DTCC00322694,1360188,16958,5.0,120,10019102,COC1CC2=CC=CC=C2C3(O1)CCN(CC3)CC4=CC=CC=C4,COC1Cc2ccccc2C2(CCN(Cc3ccccc3)CC2)O1
CHEMBL1417859,P46098,,GEIHZHQRXYKYAE-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22589534.0,IC50,=,9000.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14718733,DTCC00821177,2101711,68163,5.045757490560675,121,710987,C1=CC=C(C=C1)CSC2=NC=NC3=C2C=CS3,c1ccc(CSc2ncnc3sccc23)cc1
CHEMBL1448856,P46098,,XJIAFXBLMMIRJR-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22589534.0,IC50,=,100000.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14714397,DTCC00849945,2099633,68163,4.0,124,663391,C1=CC=C(C(=C1)CSC2=NC=NC3=C2OC4=CC=CC=C43)F,Fc1ccccc1CSc1ncnc2c1oc1ccccc12
CHEMBL1545368,P46098,,RVXFERDBNJSQDX-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22589534.0,IC50,=,100000.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14717934,DTCC00939726,2101285,68163,4.0,131,1069463,CN(C)C1=C2C3=C(C(=NC=N3)SCC4=CC=C(C=C4)Cl)SC2=NC=C1,CN(C)c1ccnc2sc3c(SCc4ccc(Cl)cc4)ncnc3c12
CHEMBL1586599,P46098,,WHCWGLIMIAJMOY-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22589534.0,IC50,=,12000.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14720929,DTCC00978021,2102135,68163,4.920818753952375,133,703907,C1CCC2=C(C1)C3=C(S2)N=CN=C3SCC4=CC=CC=C4F,Fc1ccccc1CSc1ncnc2sc3c(c12)CCCC3
CHEMBL1623875,P46098,,UMWDYBZXNCMBRO-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22589534.0,IC50,=,100000.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14717956,DTCC01011635,2101297,68163,4.0,135,2227334,CC1=CC2=C(N=CN=C2S1)NCC3=CC=CC=C3,Cc1cc2c(NCc3ccccc3)ncnc2s1
CHEMBL1748,P46098,NORCISAPRIDE,OMLDMGPCWMBPAN-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19700325.0,IC50,=,1600.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human recombinant 5-HT3 receptor expressed in HEK293 cells,,mu-Opioid/5-HT4 dual pharmacologically active agents-efforts towards an effective opioid analgesic with less GI and respiratory side effects (Part I).,Bioorg. Med. Chem. Lett.,2009.0,19.0,19.0,"Shao L, Wang F, Hewitt MC, Barberich TJ",,598654.0,DTCT0023221,3114457,DTCC00604523,715932,36218,5.795880017344075,166,3019427,COC1CNCCC1NC(=O)C2=CC(=C(C=C2OC)N)Cl,COc1cc(N)c(Cl)cc1C(=O)NC1CCNCC1OC
CHEMBL1770373,P46098,PF-3246799,CZWQBSKNHUVZLI-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21195614.0,IC50,=,2300.0,NM,,,,,,,,,,,,,,Binding affinity to 5-HT3 receptor,,"Pyrimido[4,5-d]azepines as potent and selective 5-HT(2C) receptor agonists: Design, synthesis, and evaluation of PF-3246799 as a treatment for urinary incontinence.",Bioorg. Med. Chem. Lett.,2011.0,21.0,9.0,"Andrews MD, Fish PV, Blagg J, Brabham TK, Brennan PE, Bridgeland A, Brown AD, Bungay PJ, Conlon KM, Edmunds NJ, Af Forselles K, Gibbons CP, Green MP, Hanton G, Holbrook M, Jessiman AS, McIntosh K, McMurray G, Nichols CL, Root JA, Storer RI, Sutton MR, Ward RV, Westbrook D, Whitlock GA",,744884.0,DTCT0023221,5933236,DTCC00033971,69510,44351,5.638272163982407,170,25070582,C1CNCCC2=NC(=NC=C21)CC3=CC=CC=C3,c1ccc(Cc2ncc3c(n2)CCNCC3)cc1
CHEMBL194305,P46098,,ZQZWLJUKYOXRPN-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,16055331.0,IC50,>,1000.0,NM,,cell_based,,,,,,,,,,,,Inhibitory activity against 5-hydroxytryptamine 3 receptor expressed in NG 108 cells,,"2-Alkyl-3-(1,2,3,6-tetrahydropyridin-4-yl)-1H-indoles as novel 5-HT6 receptor agonists.",Bioorg. Med. Chem. Lett.,2005.0,15.0,19.0,"Mattsson C, Sonesson C, Sandahl A, Greiner HE, Gassen M, Plaschke J, Leibrock J, Böttcher H",,321408.0,DTCT0023221,1847927,DTCC00405026,337540,19721,6.0,208,3066250,CC1=C(C2=C(N1)C=CC(=C2)OC)C3=CCNCC3,COc1ccc2[nH]c(C)c(C3=CCNCC3)c2c1
CHEMBL206666,P46098,,OSQNMWDGHFIAOM-UHFFFAOYSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904.0,IC50,>,100000.0,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells by FMP assay,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007.0,50.0,19.0,"Jensen AA, Zlotos DP, Liljefors T",,445995.0,DTCT0023221,2125494,DTCC00417470,1410574,23555,4.0,262,44408940,C[N+](C)(CC=C)CC1=C2CN3C(=C(C4=CC=CC=C43)C[N+](C)(C)CC=C)CN2C5=CC=CC=C51.[Br-].[Br-],C=CC[N+](C)(C)Cc1c2n(c3ccccc13)Cc1c(C[N+](C)(C)CC=C)c3ccccc3n1C2
CHEMBL206666,P46098,,OSQNMWDGHFIAOM-UHFFFAOYSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904.0,IC50,>,100000.0,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells by FMP assay,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007.0,50.0,19.0,"Jensen AA, Zlotos DP, Liljefors T",,445995.0,DTCT0023221,2125495,DTCC00417470,1410574,23555,4.0,262,44408940,C[N+](C)(CC=C)CC1=C2CN3C(=C(C4=CC=CC=C43)C[N+](C)(C)CC=C)CN2C5=CC=CC=C51.[Br-].[Br-],C=CC[N+](C)(C)Cc1c2n(c3ccccc13)Cc1c(C[N+](C)(C)CC=C)c3ccccc3n1C2
CHEMBL2086582,P46098,WAY-361789,LKMWIEHGNOUIAH-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22468936.0,IC50,>,30000.0,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells assessed as inhibition of m-chlorophenylbiguanide-induced calcium influx measured every 1 sec for 1 min followed by every 3 secs for 3 mins by FLIPR assay,,"Discovery of a Novel Alpha-7 Nicotinic Acetylcholine Receptor Agonist Series and Characterization of the Potent, Selective, and Orally Efficacious Agonist 5-(4-Acetyl[1,4]diazepan-1-yl)pentanoic Acid [5-(4-Methoxyphenyl)-1H-pyrazol-3-yl] Amide (SEN15924, WAY-361789).",J. Med. Chem.,2012.0,55.0,10.0,"Zanaletti R, Bettinetti L, Castaldo C, Cocconcelli G, Comery T, Dunlop J, Gaviraghi G, Ghiron C, Haydar SN, Jow F, Maccari L, Micco I, Nencini A, Scali C, Turlizzi E, Valacchi M",,842160.0,DTCT0023221,10599354,DTCC00042481,1655940,50457,4.522878745280337,264,24860582,CC(=O)N1CCCN(CC1)CCCCC(=O)NC2=NNC(=C2)C3=CC=C(C=C3)OC,COc1ccc(-c2cc(NC(=O)CCCCN3CCCN(C(C)=O)CC3)n[nH]2)cc1
CHEMBL2086584,P46098,,KELGFUJORMNBDM-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22468936.0,IC50,>,30000.0,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells assessed as inhibition of m-chlorophenylbiguanide-induced calcium influx measured every 1 sec for 1 min followed by every 3 secs for 3 mins by FLIPR assay,,"Discovery of a Novel Alpha-7 Nicotinic Acetylcholine Receptor Agonist Series and Characterization of the Potent, Selective, and Orally Efficacious Agonist 5-(4-Acetyl[1,4]diazepan-1-yl)pentanoic Acid [5-(4-Methoxyphenyl)-1H-pyrazol-3-yl] Amide (SEN15924, WAY-361789).",J. Med. Chem.,2012.0,55.0,10.0,"Zanaletti R, Bettinetti L, Castaldo C, Cocconcelli G, Comery T, Dunlop J, Gaviraghi G, Ghiron C, Haydar SN, Jow F, Maccari L, Micco I, Nencini A, Scali C, Turlizzi E, Valacchi M",,842160.0,DTCT0023221,10599355,DTCC01253700,1234562,50457,4.522878745280337,266,57523447,CC(CCCN1CCCN(CC1)C(=O)C)C(=O)NC2=NNC(=C2)C3=CC=C(C=C3)OC,COc1ccc(-c2cc(NC(=O)C(C)CCCN3CCCN(C(C)=O)CC3)n[nH]2)cc1
CHEMBL2087443,P46098,,BGJJEMSVLGIVLI-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22468936.0,IC50,>,30000.0,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells assessed as inhibition of m-chlorophenylbiguanide-induced calcium influx measured every 1 sec for 1 min followed by every 3 secs for 3 mins by FLIPR assay,,"Discovery of a Novel Alpha-7 Nicotinic Acetylcholine Receptor Agonist Series and Characterization of the Potent, Selective, and Orally Efficacious Agonist 5-(4-Acetyl[1,4]diazepan-1-yl)pentanoic Acid [5-(4-Methoxyphenyl)-1H-pyrazol-3-yl] Amide (SEN15924, WAY-361789).",J. Med. Chem.,2012.0,55.0,10.0,"Zanaletti R, Bettinetti L, Castaldo C, Cocconcelli G, Comery T, Dunlop J, Gaviraghi G, Ghiron C, Haydar SN, Jow F, Maccari L, Micco I, Nencini A, Scali C, Turlizzi E, Valacchi M",,842160.0,DTCT0023221,10599346,DTCC01254437,1202066,50457,4.522878745280337,275,57523356,COC1=CC=C(C=C1)C2=CC(=NN2)NC(=O)CCCCN3CCCCC3,COc1ccc(-c2cc(NC(=O)CCCCN3CCCCC3)n[nH]2)cc1
CHEMBL2087445,P46098,,YJOREKPBKODAPH-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22468936.0,IC50,>,30000.0,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells assessed as inhibition of m-chlorophenylbiguanide-induced calcium influx measured every 1 sec for 1 min followed by every 3 secs for 3 mins by FLIPR assay,,"Discovery of a Novel Alpha-7 Nicotinic Acetylcholine Receptor Agonist Series and Characterization of the Potent, Selective, and Orally Efficacious Agonist 5-(4-Acetyl[1,4]diazepan-1-yl)pentanoic Acid [5-(4-Methoxyphenyl)-1H-pyrazol-3-yl] Amide (SEN15924, WAY-361789).",J. Med. Chem.,2012.0,55.0,10.0,"Zanaletti R, Bettinetti L, Castaldo C, Cocconcelli G, Comery T, Dunlop J, Gaviraghi G, Ghiron C, Haydar SN, Jow F, Maccari L, Micco I, Nencini A, Scali C, Turlizzi E, Valacchi M",,842160.0,DTCT0023221,10599347,DTCC01254439,1908971,50457,4.522878745280337,277,57523382,COC1=CC=CC=C1C2=CC(=NN2)NC(=O)CCCCN3CCCCC3,COc1ccccc1-c1cc(NC(=O)CCCCN2CCCCC2)n[nH]1
CHEMBL2087447,P46098,,POWHTVORLJYXLJ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22468936.0,IC50,>,30000.0,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells assessed as inhibition of m-chlorophenylbiguanide-induced calcium influx measured every 1 sec for 1 min followed by every 3 secs for 3 mins by FLIPR assay,,"Discovery of a Novel Alpha-7 Nicotinic Acetylcholine Receptor Agonist Series and Characterization of the Potent, Selective, and Orally Efficacious Agonist 5-(4-Acetyl[1,4]diazepan-1-yl)pentanoic Acid [5-(4-Methoxyphenyl)-1H-pyrazol-3-yl] Amide (SEN15924, WAY-361789).",J. Med. Chem.,2012.0,55.0,10.0,"Zanaletti R, Bettinetti L, Castaldo C, Cocconcelli G, Comery T, Dunlop J, Gaviraghi G, Ghiron C, Haydar SN, Jow F, Maccari L, Micco I, Nencini A, Scali C, Turlizzi E, Valacchi M",,842160.0,DTCT0023221,10599348,DTCC01254441,1461939,50457,4.522878745280337,279,24997749,C1CCN(CC1)CCCCC(=O)NC2=NNC(=C2)C3=CC=C(C=C3)F,O=C(CCCCN1CCCCC1)Nc1cc(-c2ccc(F)cc2)[nH]n1
CHEMBL2087448,P46098,,MIQNWMJNRQADMN-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22468936.0,IC50,>,30000.0,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells assessed as inhibition of m-chlorophenylbiguanide-induced calcium influx measured every 1 sec for 1 min followed by every 3 secs for 3 mins by FLIPR assay,,"Discovery of a Novel Alpha-7 Nicotinic Acetylcholine Receptor Agonist Series and Characterization of the Potent, Selective, and Orally Efficacious Agonist 5-(4-Acetyl[1,4]diazepan-1-yl)pentanoic Acid [5-(4-Methoxyphenyl)-1H-pyrazol-3-yl] Amide (SEN15924, WAY-361789).",J. Med. Chem.,2012.0,55.0,10.0,"Zanaletti R, Bettinetti L, Castaldo C, Cocconcelli G, Comery T, Dunlop J, Gaviraghi G, Ghiron C, Haydar SN, Jow F, Maccari L, Micco I, Nencini A, Scali C, Turlizzi E, Valacchi M",,842160.0,DTCT0023221,10599350,DTCC01254442,362627,50457,4.522878745280337,280,57523383,C1CCN(CC1)CCCCC(=O)NC2=NNC(=C2)C3=CC=C(C=C3)Br,O=C(CCCCN1CCCCC1)Nc1cc(-c2ccc(Br)cc2)[nH]n1
CHEMBL2087453,P46098,,RPLWNHKGFXWLSL-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22468936.0,IC50,>,30000.0,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells assessed as inhibition of m-chlorophenylbiguanide-induced calcium influx measured every 1 sec for 1 min followed by every 3 secs for 3 mins by FLIPR assay,,"Discovery of a Novel Alpha-7 Nicotinic Acetylcholine Receptor Agonist Series and Characterization of the Potent, Selective, and Orally Efficacious Agonist 5-(4-Acetyl[1,4]diazepan-1-yl)pentanoic Acid [5-(4-Methoxyphenyl)-1H-pyrazol-3-yl] Amide (SEN15924, WAY-361789).",J. Med. Chem.,2012.0,55.0,10.0,"Zanaletti R, Bettinetti L, Castaldo C, Cocconcelli G, Comery T, Dunlop J, Gaviraghi G, Ghiron C, Haydar SN, Jow F, Maccari L, Micco I, Nencini A, Scali C, Turlizzi E, Valacchi M",,842160.0,DTCT0023221,10599351,DTCC01254448,685678,50457,4.522878745280337,285,24998360,COC1=CC=C(C=C1)C2=CC(=NN2)NC(=O)CCCCN3CCOCC3,COc1ccc(-c2cc(NC(=O)CCCCN3CCOCC3)n[nH]2)cc1
CHEMBL2087456,P46098,,LZQMVVGBOPZASC-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22468936.0,IC50,>,30000.0,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells assessed as inhibition of m-chlorophenylbiguanide-induced calcium influx measured every 1 sec for 1 min followed by every 3 secs for 3 mins by FLIPR assay,,"Discovery of a Novel Alpha-7 Nicotinic Acetylcholine Receptor Agonist Series and Characterization of the Potent, Selective, and Orally Efficacious Agonist 5-(4-Acetyl[1,4]diazepan-1-yl)pentanoic Acid [5-(4-Methoxyphenyl)-1H-pyrazol-3-yl] Amide (SEN15924, WAY-361789).",J. Med. Chem.,2012.0,55.0,10.0,"Zanaletti R, Bettinetti L, Castaldo C, Cocconcelli G, Comery T, Dunlop J, Gaviraghi G, Ghiron C, Haydar SN, Jow F, Maccari L, Micco I, Nencini A, Scali C, Turlizzi E, Valacchi M",,842160.0,DTCT0023221,10599352,DTCC01254451,1106332,50457,4.522878745280337,288,57523414,COC1=CC=C(C=C1)C2=CC(=NN2)NC(=O)CCCCN3CCCCCC3,COc1ccc(-c2cc(NC(=O)CCCCN3CCCCCC3)n[nH]2)cc1
CHEMBL2087457,P46098,,PNHTUMMCJLWVTR-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22468936.0,IC50,>,30000.0,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells assessed as inhibition of m-chlorophenylbiguanide-induced calcium influx measured every 1 sec for 1 min followed by every 3 secs for 3 mins by FLIPR assay,,"Discovery of a Novel Alpha-7 Nicotinic Acetylcholine Receptor Agonist Series and Characterization of the Potent, Selective, and Orally Efficacious Agonist 5-(4-Acetyl[1,4]diazepan-1-yl)pentanoic Acid [5-(4-Methoxyphenyl)-1H-pyrazol-3-yl] Amide (SEN15924, WAY-361789).",J. Med. Chem.,2012.0,55.0,10.0,"Zanaletti R, Bettinetti L, Castaldo C, Cocconcelli G, Comery T, Dunlop J, Gaviraghi G, Ghiron C, Haydar SN, Jow F, Maccari L, Micco I, Nencini A, Scali C, Turlizzi E, Valacchi M",,842160.0,DTCT0023221,10599353,DTCC01254452,2071504,50457,4.522878745280337,289,57523415,COC1=CC=C(C=C1)C2=CC(=NN2)NC(=O)CCCCN3CCCOCC3,COc1ccc(-c2cc(NC(=O)CCCCN3CCCOCC3)n[nH]2)cc1
CHEMBL2151572,P46098,ENCENICLINE,SSRDSYXGYPJKRR-ZDUSSCGKSA-N,3,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21919481.0,IC50,=,299.0,NM,,,,,,,,,,,,,,Binding affinity to 5HT3 receptor,,Discovery and development of a7 nicotinic acetylcholine receptor modulators.,J. Med. Chem.,2011.0,54.0,23.0,"Mazurov AA, Speake JD, Yohannes D",,851152.0,DTCT0023221,11361601,DTCC01284663,641412,50968,6.52432881167557,298,46196517,C1CN2CCC1C(C2)NC(=O)C3=CC4=C(S3)C(=CC=C4)Cl,O=C(NC1CN2CCC1CC2)c1cc2cccc(Cl)c2s1
CHEMBL2179217,P46098,,ZPUAIXYROPYWKA-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23006002.0,IC50,>,10000.0,NM,,,,,,,,,,,,,,Binding affinity to 5HT3 receptor,,"Design, Synthesis, and Pharmacological Evaluation of Piperidin-4-yl amino aryl sulfonamides: Novel, Potent, Selective, Orally Active, and Brain Penetrant 5-HT(6) Receptor Antagonists.",J. Med. Chem.,2012.0,55.0,21.0,"Nirogi R, Shinde A, Daulatabad A, Kambhampati R, Gudla P, Shaik M, Gampa M, Balasubramaniam S, Gangadasari P, Reballi V, Badange R, Bojja K, Subramanian R, Bhyrapuneni G, Muddana N, Jayarajan P",,875715.0,DTCT0023221,11435578,DTCC01295975,641546,51583,5.0,315,71457264,CC1=CN(C2=C1C=C(C=C2)Cl)S(=O)(=O)C3=CC(=C(C=C3)OC)NC4CCN(CC4)C,COc1ccc(S(=O)(=O)n2cc(C)c3cc(Cl)ccc32)cc1NC1CCN(C)CC1
CHEMBL2179222,P46098,,XRDVQWJPAZZLKN-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23006002.0,IC50,>,10000.0,NM,,,,,,,,,,,,,,Binding affinity to 5HT3 receptor,,"Design, Synthesis, and Pharmacological Evaluation of Piperidin-4-yl amino aryl sulfonamides: Novel, Potent, Selective, Orally Active, and Brain Penetrant 5-HT(6) Receptor Antagonists.",J. Med. Chem.,2012.0,55.0,21.0,"Nirogi R, Shinde A, Daulatabad A, Kambhampati R, Gudla P, Shaik M, Gampa M, Balasubramaniam S, Gangadasari P, Reballi V, Badange R, Bojja K, Subramanian R, Bhyrapuneni G, Muddana N, Jayarajan P",,875715.0,DTCT0023221,11435577,DTCC01295978,1028954,51583,5.0,316,51002362,CC1=CN(C2=C1C=C(C=N2)Cl)S(=O)(=O)C3=CC(=C(C=C3)OC)NC4CCN(CC4)C,COc1ccc(S(=O)(=O)n2cc(C)c3cc(Cl)cnc32)cc1NC1CCN(C)CC1
CHEMBL2180835,P46098,,OUTWSZAPEGAWEL-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23083093.0,IC50,>,31622.78,NM,,cell_based,,,,,,,,,,,HEK293,Agonist activity at human 5HT3R expressed in HEK293 cells assessed as stimulation of calcium flux by FLIPR,,"N-[5-(5-Fluoropyridin-3-yl)-1H-pyrazol-3-yl]-4-piperidin-1-ylbutyramide (SEN78702, WYE-308775): A Medicinal Chemistry Effort toward an a7 Nicotinic Acetylcholine Receptor Agonist Preclinical Candidate.",J. Med. Chem.,2012.0,55.0,22.0,"Zanaletti R, Bettinetti L, Castaldo C, Ceccarelli I, Cocconcelli G, Comery TA, Dunlop J, Genesio E, Ghiron C, Haydar SN, Jow F, Maccari L, Micco I, Nencini A, Pratelli C, Scali C, Turlizzi E, Valacchi M",,877121.0,DTCT0023221,11442258,DTCC01297487,1832542,51641,4.499999953328896,328,25029711,COC1=CC=C(C=C1)C2=CC(=NN2)NC(=O)CCCN3CCCCC3,COc1ccc(-c2cc(NC(=O)CCCN3CCCCC3)n[nH]2)cc1
CHEMBL2180836,P46098,,KOTAZQOZDGBEDN-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23083093.0,IC50,>,31622.78,NM,,cell_based,,,,,,,,,,,HEK293,Agonist activity at human 5HT3R expressed in HEK293 cells assessed as stimulation of calcium flux by FLIPR,,"N-[5-(5-Fluoropyridin-3-yl)-1H-pyrazol-3-yl]-4-piperidin-1-ylbutyramide (SEN78702, WYE-308775): A Medicinal Chemistry Effort toward an a7 Nicotinic Acetylcholine Receptor Agonist Preclinical Candidate.",J. Med. Chem.,2012.0,55.0,22.0,"Zanaletti R, Bettinetti L, Castaldo C, Ceccarelli I, Cocconcelli G, Comery TA, Dunlop J, Genesio E, Ghiron C, Haydar SN, Jow F, Maccari L, Micco I, Nencini A, Pratelli C, Scali C, Turlizzi E, Valacchi M",,877121.0,DTCT0023221,11442257,DTCC01297488,479953,51641,4.499999953328896,329,59173799,COC1=CC=C(C=C1)C2=CC(=NN2)NC(=O)CCCN3CCCCCC3,COc1ccc(-c2cc(NC(=O)CCCN3CCCCCC3)n[nH]2)cc1
CHEMBL2204360,P46098,,JOJYHYRCIYAVHN-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21486038.0,IC50,=,12.0,NM,,cell_based,,,,,,,,,,,Oocytes,Antagonist activity at human 5HT3A receptor expressed in xenopus oocytes assessed as inhibition of 5HT-induced effect by electrophysiological method,,"Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): A Novel Multimodal Compound for the Treatment of Major Depressive Disorder.",J. Med. Chem.,2011.0,54.0,9.0,"Bang-Andersen B, Ruhland T, Jørgensen M, Smith G, Frederiksen K, Jensen KG, Zhong H, Nielsen SM, Hogg S, Mørk A, Stensbøl TB",,880244.0,DTCT0023221,11460195,DTCC01299713,1748126,51828,7.920818753952375,347,66860907,CC1=CC(=C(C=C1)SC2=CC=CC=C2N3CCNCC3)C.Cl,Cc1ccc(Sc2ccccc2N2CCNCC2)c(C)c1
CHEMBL220808,P46098,SARIZOTAN,HKFMQJUJWSFOLY-OAQYLSRUSA-N,3,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,18181565.0,IC50,<,6.0,NM,,,,,,,,,,,,,,Binding affinity to 5HT3 receptor,,Multi-target-directed ligands to combat neurodegenerative diseases.,J. Med. Chem.,2008.0,51.0,3.0,"Cavalli A, Bolognesi ML, Minarini A, Rosini M, Tumiatti V, Recanatini M, Melchiorre C",,462123.0,DTCT0023221,2280978,DTCC00439481,1296638,25139,8.221848749616356,397,6918388,C1CC2=CC=CC=C2OC1CNCC3=CC(=CN=C3)C4=CC=C(C=C4)F,Fc1ccc(-c2cncc(CNCC3CCc4ccccc4O3)c2)cc1
CHEMBL223331,P46098,KKHT-10608,YKQRXGQZAGVEJY-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19447040.0,IC50,=,2400.0,NM,,,,,,,,,,,,,,Antagonist activity at 5HT3A receptor expressed in Xenopus oocyte,,Quinazolindione derivatives as potent 5-HT3A receptor antagonists.,Bioorg. Med. Chem.,2009.0,17.0,13.0,"Lee BH, Choi MJ, Jo MN, Seo HJ, Nah SY, Cho YS, Nam G, Pae AN, Rhim H, Choo H",,578446.0,DTCT0023221,2887680,DTCC00002546,1885925,34988,5.619788758288394,398,25196629,C1CCN(CC1)CCNC(=O)C2=CC3=C(C=C2)C(=O)N(C(=O)N3)CC4=CC(=CC=C4)F,O=C(NCCN1CCCCC1)c1ccc2c(=O)n(Cc3cccc(F)c3)c(=O)[nH]c2c1
CHEMBL223387,P46098,,XKRVOMXWYNEPTN-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19447040.0,IC50,=,1400.0,NM,,,,,,,,,,,,,,Antagonist activity at 5HT3A receptor expressed in Xenopus oocyte,,Quinazolindione derivatives as potent 5-HT3A receptor antagonists.,Bioorg. Med. Chem.,2009.0,17.0,13.0,"Lee BH, Choi MJ, Jo MN, Seo HJ, Nah SY, Cho YS, Nam G, Pae AN, Rhim H, Choo H",,578446.0,DTCT0023221,2887682,DTCC00447015,37738,34988,5.853871964321762,399,25196631,COC1=CC=CC=C1CN2C(=O)C3=C(C=C(C=C3)C(=O)NCCN4CCCCC4)NC2=O,COc1ccccc1Cn1c(=O)[nH]c2cc(C(=O)NCCN3CCCCC3)ccc2c1=O
CHEMBL223715,P46098,KKHT-10612,RLQXOTMOPGYNGI-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19447040.0,IC50,=,800.0,NM,,,,,,,,,,,,,,Antagonist activity at 5HT3A receptor expressed in Xenopus oocyte,,Quinazolindione derivatives as potent 5-HT3A receptor antagonists.,Bioorg. Med. Chem.,2009.0,17.0,13.0,"Lee BH, Choi MJ, Jo MN, Seo HJ, Nah SY, Cho YS, Nam G, Pae AN, Rhim H, Choo H",,578446.0,DTCT0023221,2887684,DTCC00002548,1211131,34988,6.096910013008056,400,25191018,COC1=CC=C(C=C1)CN2C(=O)C3=C(C=C(C=C3)C(=O)NCCN4CCCCC4)NC2=O,COc1ccc(Cn2c(=O)[nH]c3cc(C(=O)NCCN4CCCCC4)ccc3c2=O)cc1
CHEMBL223951,P46098,KKHT-10617,FIJJTIJVCAYUQE-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19447040.0,IC50,=,2100.0,NM,,,,,,,,,,,,,,Antagonist activity at 5HT3A receptor expressed in Xenopus oocyte,,Quinazolindione derivatives as potent 5-HT3A receptor antagonists.,Bioorg. Med. Chem.,2009.0,17.0,13.0,"Lee BH, Choi MJ, Jo MN, Seo HJ, Nah SY, Cho YS, Nam G, Pae AN, Rhim H, Choo H",,578446.0,DTCT0023221,2887688,DTCC00002553,1536021,34988,5.6777807052660805,401,44422216,C1CCN(CC1)CCNC(=O)C2=CC3=C(C=C2)C(=O)N(C(=O)N3)CC4=CC=CC=C4Cl,O=C(NCCN1CCCCC1)c1ccc2c(=O)n(Cc3ccccc3Cl)c(=O)[nH]c2c1
CHEMBL224008,P46098,,ISRIWKVGGLFNBT-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19447040.0,IC50,=,2700.0,NM,,,,,,,,,,,,,,Antagonist activity at 5HT3A receptor expressed in Xenopus oocyte,,Quinazolindione derivatives as potent 5-HT3A receptor antagonists.,Bioorg. Med. Chem.,2009.0,17.0,13.0,"Lee BH, Choi MJ, Jo MN, Seo HJ, Nah SY, Cho YS, Nam G, Pae AN, Rhim H, Choo H",,578446.0,DTCT0023221,2887683,DTCC00111170,727227,34988,5.568636235841013,402,25196632,COC1=CC=CC(=C1)CN2C(=O)C3=C(C=C(C=C3)C(=O)NCCN4CCCCC4)NC2=O,COc1cccc(Cn2c(=O)[nH]c3cc(C(=O)NCCN4CCCCC4)ccc3c2=O)c1
CHEMBL224159,P46098,KKHT-10109,JXEWFPXPEYRYSN-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19447040.0,IC50,=,19800.0,NM,,,,,,,,,,,,,,Antagonist activity at 5HT3A receptor expressed in Xenopus oocyte,,Quinazolindione derivatives as potent 5-HT3A receptor antagonists.,Bioorg. Med. Chem.,2009.0,17.0,13.0,"Lee BH, Choi MJ, Jo MN, Seo HJ, Nah SY, Cho YS, Nam G, Pae AN, Rhim H, Choo H",,578446.0,DTCT0023221,2887674,DTCC00002555,1726697,34988,4.703334809738469,403,44422228,C1COCCN1CCNC(=O)C2=CC3=C(C=C2)C(=O)N(C(=O)N3)CC4=CC=C(C=C4)F,O=C(NCCN1CCOCC1)c1ccc2c(=O)n(Cc3ccc(F)cc3)c(=O)[nH]c2c1
CHEMBL224160,P46098,KKHT-11118,FXRGLPUKLPILJM-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19447040.0,IC50,=,2800.0,NM,,,,,,,,,,,,,,Antagonist activity at 5HT3A receptor expressed in Xenopus oocyte,,Quinazolindione derivatives as potent 5-HT3A receptor antagonists.,Bioorg. Med. Chem.,2009.0,17.0,13.0,"Lee BH, Choi MJ, Jo MN, Seo HJ, Nah SY, Cho YS, Nam G, Pae AN, Rhim H, Choo H",,578446.0,DTCT0023221,2885914,DTCC00002557,727237,34988,5.552841968657781,404,25196744,CC1CCCCN1CCNC(=O)C2=CC3=C(C=C2)C(=O)N(C(=O)N3)CC4=CC=C(C=C4)Cl,CC1CCCCN1CCNC(=O)c1ccc2c(=O)n(Cc3ccc(Cl)cc3)c(=O)[nH]c2c1
CHEMBL224227,P46098,KKHT-20718,YMGCQAHDDYCKLB-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19447040.0,IC50,=,11600.0,NM,,,,,,,,,,,,,,Antagonist activity at 5HT3A receptor expressed in Xenopus oocyte,,Quinazolindione derivatives as potent 5-HT3A receptor antagonists.,Bioorg. Med. Chem.,2009.0,17.0,13.0,"Lee BH, Choi MJ, Jo MN, Seo HJ, Nah SY, Cho YS, Nam G, Pae AN, Rhim H, Choo H",,578446.0,DTCT0023221,2885917,DTCC00002561,1950838,34988,4.935542010773082,405,25196850,CC1CCCCN1CCCNC(=O)C2=CC3=C(C=C2)C(=O)N(C(=O)N3)CC4=CC=C(C=C4)Cl,CC1CCCCN1CCCNC(=O)c1ccc2c(=O)n(Cc3ccc(Cl)cc3)c(=O)[nH]c2c1
CHEMBL224246,P46098,KKHT-20918,IWAHUQRZIUVMSG-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19447040.0,IC50,=,5700.0,NM,,,,,,,,,,,,,,Antagonist activity at 5HT3A receptor expressed in Xenopus oocyte,,Quinazolindione derivatives as potent 5-HT3A receptor antagonists.,Bioorg. Med. Chem.,2009.0,17.0,13.0,"Lee BH, Choi MJ, Jo MN, Seo HJ, Nah SY, Cho YS, Nam G, Pae AN, Rhim H, Choo H",,578446.0,DTCT0023221,2885919,DTCC00002563,1697132,34988,5.2441251443275085,406,25196851,C1CCN(CC1)CCCNC(=O)C2=CC3=C(C=C2)C(=O)N(C(=O)N3)CC4=CC=C(C=C4)Cl,O=C(NCCCN1CCCCC1)c1ccc2c(=O)n(Cc3ccc(Cl)cc3)c(=O)[nH]c2c1
CHEMBL224310,P46098,KKHT-20218,WLYLIKBNGQZDFH-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19447040.0,IC50,=,1300.0,NM,,,,,,,,,,,,,,Antagonist activity at 5HT3A receptor expressed in Xenopus oocyte,,Quinazolindione derivatives as potent 5-HT3A receptor antagonists.,Bioorg. Med. Chem.,2009.0,17.0,13.0,"Lee BH, Choi MJ, Jo MN, Seo HJ, Nah SY, Cho YS, Nam G, Pae AN, Rhim H, Choo H",,578446.0,DTCT0023221,2885915,DTCC00002556,856886,34988,5.886056647693163,407,25196745,C1COCCN1CCCNC(=O)C2=CC3=C(C=C2)C(=O)N(C(=O)N3)CC4=CC=C(C=C4)Cl,O=C(NCCCN1CCOCC1)c1ccc2c(=O)n(Cc3ccc(Cl)cc3)c(=O)[nH]c2c1
CHEMBL224389,P46098,KKHT-10603,NVNVERQZWUUANS-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19447040.0,IC50,=,1900.0,NM,,,,,,,,,,,,,,Antagonist activity at 5HT3A receptor expressed in Xenopus oocyte,,Quinazolindione derivatives as potent 5-HT3A receptor antagonists.,Bioorg. Med. Chem.,2009.0,17.0,13.0,"Lee BH, Choi MJ, Jo MN, Seo HJ, Nah SY, Cho YS, Nam G, Pae AN, Rhim H, Choo H",,578446.0,DTCT0023221,2887677,DTCC00002559,1083040,34988,5.721246399047171,408,24804735,C1CCN(CC1)CCNC(=O)C2=CC3=C(C=C2)C(=O)N(C(=O)N3)C4=CC=C(C=C4)F,O=C(NCCN1CCCCC1)c1ccc2c(=O)n(-c3ccc(F)cc3)c(=O)[nH]c2c1
CHEMBL224641,P46098,KKHT-20713,CVIIPJUPHIOKNG-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19447040.0,IC50,=,5900.0,NM,,,,,,,,,,,,,,Antagonist activity at 5HT3A receptor expressed in Xenopus oocyte,,Quinazolindione derivatives as potent 5-HT3A receptor antagonists.,Bioorg. Med. Chem.,2009.0,17.0,13.0,"Lee BH, Choi MJ, Jo MN, Seo HJ, Nah SY, Cho YS, Nam G, Pae AN, Rhim H, Choo H",,578446.0,DTCT0023221,2885916,DTCC00002564,1950849,34988,5.229147988357856,409,44422338,CC1CCCCN1CCCNC(=O)C2=CC3=C(C=C2)C(=O)N(C(=O)N3)C4CCCCC4,CC1CCCCN1CCCNC(=O)c1ccc2c(=O)n(C3CCCCC3)c(=O)[nH]c2c1
CHEMBL224648,P46098,KKHT-10118,KINBZTGMJRQTER-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19447040.0,IC50,=,15800.0,NM,,,,,,,,,,,,,,Antagonist activity at 5HT3A receptor expressed in Xenopus oocyte,,Quinazolindione derivatives as potent 5-HT3A receptor antagonists.,Bioorg. Med. Chem.,2009.0,17.0,13.0,"Lee BH, Choi MJ, Jo MN, Seo HJ, Nah SY, Cho YS, Nam G, Pae AN, Rhim H, Choo H",,578446.0,DTCT0023221,2887675,DTCC00002558,1789145,34988,4.801342913045577,410,44422255,C1COCCN1CCNC(=O)C2=CC3=C(C=C2)C(=O)N(C(=O)N3)CC4=CC=C(C=C4)Cl,O=C(NCCN1CCOCC1)c1ccc2c(=O)n(Cc3ccc(Cl)cc3)c(=O)[nH]c2c1
CHEMBL224701,P46098,KKHT-10606,DPMQWTNICFCLFP-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19447040.0,IC50,=,1600.0,NM,,,,,,,,,,,,,,Antagonist activity at 5HT3A receptor expressed in Xenopus oocyte,,Quinazolindione derivatives as potent 5-HT3A receptor antagonists.,Bioorg. Med. Chem.,2009.0,17.0,13.0,"Lee BH, Choi MJ, Jo MN, Seo HJ, Nah SY, Cho YS, Nam G, Pae AN, Rhim H, Choo H",,578446.0,DTCT0023221,2887678,DTCC00002560,1017971,34988,5.795880017344075,411,25196518,COC1=CC=C(C=C1)N2C(=O)C3=C(C=C(C=C3)C(=O)NCCN4CCCCC4)NC2=O,COc1ccc(-n2c(=O)[nH]c3cc(C(=O)NCCN4CCCCC4)ccc3c2=O)cc1
CHEMBL224766,P46098,KKHT-10615,DWGFHYJCLFQFTA-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19447040.0,IC50,=,2200.0,NM,,,,,,,,,,,,,,Antagonist activity at 5HT3A receptor expressed in Xenopus oocyte,,Quinazolindione derivatives as potent 5-HT3A receptor antagonists.,Bioorg. Med. Chem.,2009.0,17.0,13.0,"Lee BH, Choi MJ, Jo MN, Seo HJ, Nah SY, Cho YS, Nam G, Pae AN, Rhim H, Choo H",,578446.0,DTCT0023221,2887687,DTCC00002552,1821673,34988,5.657577319177793,412,25196741,CN1C(=O)C2=C(C=C(C=C2)C(=O)NCCN3CCCCC3)NC1=O,Cn1c(=O)[nH]c2cc(C(=O)NCCN3CCCCC3)ccc2c1=O
CHEMBL224778,P46098,KKHT-10609,PYCLIFABZLPONX-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19447040.0,IC50,=,1900.0,NM,,,,,,,,,,,,,,Antagonist activity at 5HT3A receptor expressed in Xenopus oocyte,,Quinazolindione derivatives as potent 5-HT3A receptor antagonists.,Bioorg. Med. Chem.,2009.0,17.0,13.0,"Lee BH, Choi MJ, Jo MN, Seo HJ, Nah SY, Cho YS, Nam G, Pae AN, Rhim H, Choo H",,578446.0,DTCT0023221,2887681,DTCC00002547,1276680,34988,5.721246399047171,413,25196630,C1CCN(CC1)CCNC(=O)C2=CC3=C(C=C2)C(=O)N(C(=O)N3)CC4=CC=C(C=C4)F,O=C(NCCN1CCCCC1)c1ccc2c(=O)n(Cc3ccc(F)cc3)c(=O)[nH]c2c1
CHEMBL225484,P46098,KKHT-10607,JRKIQFPYQPIURM-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19447040.0,IC50,=,2100.0,NM,,,,,,,,,,,,,,Antagonist activity at 5HT3A receptor expressed in Xenopus oocyte,,Quinazolindione derivatives as potent 5-HT3A receptor antagonists.,Bioorg. Med. Chem.,2009.0,17.0,13.0,"Lee BH, Choi MJ, Jo MN, Seo HJ, Nah SY, Cho YS, Nam G, Pae AN, Rhim H, Choo H",,578446.0,DTCT0023221,2887679,DTCC00002544,823981,34988,5.6777807052660805,414,25196628,C1CCN(CC1)CCNC(=O)C2=CC3=C(C=C2)C(=O)N(C(=O)N3)CC4=CC=CC=C4F,O=C(NCCN1CCCCC1)c1ccc2c(=O)n(Cc3ccccc3F)c(=O)[nH]c2c1
CHEMBL225485,P46098,KKHT-11018,FKCDNDBJVOQPJB-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19447040.0,IC50,=,13600.0,NM,,,,,,,,,,,,,,Antagonist activity at 5HT3A receptor expressed in Xenopus oocyte,,Quinazolindione derivatives as potent 5-HT3A receptor antagonists.,Bioorg. Med. Chem.,2009.0,17.0,13.0,"Lee BH, Choi MJ, Jo MN, Seo HJ, Nah SY, Cho YS, Nam G, Pae AN, Rhim H, Choo H",,578446.0,DTCT0023221,2887690,DTCC00002545,953339,34988,4.866461091629782,415,44422187,CCC1CCCCN1CCNC(=O)C2=CC3=C(C=C2)C(=O)N(C(=O)N3)CC4=CC=C(C=C4)Cl,CCC1CCCCN1CCNC(=O)c1ccc2c(=O)n(Cc3ccc(Cl)cc3)c(=O)[nH]c2c1
CHEMBL225543,P46098,KKHT-10613,NNJAFUNKEIDAAF-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19447040.0,IC50,=,2000.0,NM,,,,,,,,,,,,,,Antagonist activity at 5HT3A receptor expressed in Xenopus oocyte,,Quinazolindione derivatives as potent 5-HT3A receptor antagonists.,Bioorg. Med. Chem.,2009.0,17.0,13.0,"Lee BH, Choi MJ, Jo MN, Seo HJ, Nah SY, Cho YS, Nam G, Pae AN, Rhim H, Choo H",,578446.0,DTCT0023221,2887685,DTCC00002549,339411,34988,5.698970004336019,416,25196633,C1CCC(CC1)N2C(=O)C3=C(C=C(C=C3)C(=O)NCCN4CCCCC4)NC2=O,O=C(NCCN1CCCCC1)c1ccc2c(=O)n(C3CCCCC3)c(=O)[nH]c2c1
CHEMBL225600,P46098,KKHT-10614,FALASSBEVXPICK-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19447040.0,IC50,=,2200.0,NM,,,,,,,,,,,,,,Antagonist activity at 5HT3A receptor expressed in Xenopus oocyte,,Quinazolindione derivatives as potent 5-HT3A receptor antagonists.,Bioorg. Med. Chem.,2009.0,17.0,13.0,"Lee BH, Choi MJ, Jo MN, Seo HJ, Nah SY, Cho YS, Nam G, Pae AN, Rhim H, Choo H",,578446.0,DTCT0023221,2887686,DTCC00002550,791496,34988,5.657577319177793,417,25196740,CCCN1C(=O)C2=C(C=C(C=C2)C(=O)NCCN3CCCCC3)NC1=O,CCCn1c(=O)[nH]c2cc(C(=O)NCCN3CCCCC3)ccc2c1=O
CHEMBL229998,P46098,,HCPLJHRNFWGIEM-XSHQRCBMSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904.0,IC50,>,100000.0,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells by FMP assay,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007.0,50.0,19.0,"Jensen AA, Zlotos DP, Liljefors T",,445995.0,DTCT0023221,2125510,DTCC00457685,795055,23555,4.0,421,44427872,C1C[N+]2(CC3=CCOC4C5C3CC2C1C5N(C6C7C8CC9C1(C7N4C2=CC=CC=C21)CC[N+]9(CC8=CCO6)CC1=CC=C(C=C1)[N+](=O)[O-])C1=CC=CC=C1)CC1=CC=C(C=C1)[N+](=O)[O-].[Br-].[Br-],O=[N+]([O-])c1ccc(C[N+]23CCC4C5C6C(CC42)C(=CCOC6N2c4ccccc4C46CC[N+]7(Cc8ccc([N+](=O)[O-])cc8)CC8=CCOC(C(C8CC47)C26)N5c2ccccc2)C3)cc1
CHEMBL229998,P46098,,HCPLJHRNFWGIEM-XSHQRCBMSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904.0,IC50,>,100000.0,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells by FMP assay,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007.0,50.0,19.0,"Jensen AA, Zlotos DP, Liljefors T",,445995.0,DTCT0023221,2125511,DTCC00457685,795055,23555,4.0,421,44427872,C1C[N+]2(CC3=CCOC4C5C3CC2C1C5N(C6C7C8CC9C1(C7N4C2=CC=CC=C21)CC[N+]9(CC8=CCO6)CC1=CC=C(C=C1)[N+](=O)[O-])C1=CC=CC=C1)CC1=CC=C(C=C1)[N+](=O)[O-].[Br-].[Br-],O=[N+]([O-])c1ccc(C[N+]23CCC4C5C6C(CC42)C(=CCOC6N2c4ccccc4C46CC[N+]7(Cc8ccc([N+](=O)[O-])cc8)CC8=CCOC(C(C8CC47)C26)N5c2ccccc2)C3)cc1
CHEMBL229999,P46098,,AKEMSLQKCWUTEN-UHFFFAOYSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904.0,IC50,=,30000.0,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells by FMP assay,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007.0,50.0,19.0,"Jensen AA, Zlotos DP, Liljefors T",,445995.0,DTCT0023221,2125492,DTCC00457692,244448,23555,4.522878745280337,422,17758335,C[N+](C)(CC1=CC=C(C=C1)[N+](=O)[O-])CC2=C3CN4C(=C(C5=CC=CC=C54)C[N+](C)(C)CC6=CC=C(C=C6)[N+](=O)[O-])CN3C7=CC=CC=C72.[Br-].[Br-],C[N+](C)(Cc1ccc([N+](=O)[O-])cc1)Cc1c2n(c3ccccc13)Cc1c(C[N+](C)(C)Cc3ccc([N+](=O)[O-])cc3)c3ccccc3n1C2
CHEMBL229999,P46098,,AKEMSLQKCWUTEN-UHFFFAOYSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904.0,IC50,=,31622.78,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells by FMP assay,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007.0,50.0,19.0,"Jensen AA, Zlotos DP, Liljefors T",,445995.0,DTCT0023221,2125493,DTCC00457692,244448,23555,4.499999953328896,422,17758335,C[N+](C)(CC1=CC=C(C=C1)[N+](=O)[O-])CC2=C3CN4C(=C(C5=CC=CC=C54)C[N+](C)(C)CC6=CC=C(C=C6)[N+](=O)[O-])CN3C7=CC=CC=C72.[Br-].[Br-],C[N+](C)(Cc1ccc([N+](=O)[O-])cc1)Cc1c2n(c3ccccc13)Cc1c(C[N+](C)(C)Cc3ccc([N+](=O)[O-])cc3)c3ccccc3n1C2
CHEMBL230952,P46098,,RATRRVRGHOXNQU-USTOHRNASA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904.0,IC50,=,100000.0,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells by FMP assay,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007.0,50.0,19.0,"Jensen AA, Zlotos DP, Liljefors T",,445995.0,DTCT0023221,2125522,DTCC00457678,2052137,23555,4.0,424,44427860,CC=CC[N+]12CCC3C1CC4C5C3N(C6C7C8CC9C1(C7N(C5OCC=C4C2)C2=CC=CC=C21)CC[N+]9(CC8=CCO6)CC=CC)C1=CC=CC=C1.[Br-].[Br-],CC=CC[N+]12CCC3C4C5C(CC31)C(=CCOC5N1c3ccccc3C35CC[N+]6(CC=CC)CC7=CCOC(C(C7CC36)C15)N4c1ccccc1)C2
CHEMBL230952,P46098,,RATRRVRGHOXNQU-USTOHRNASA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904.0,IC50,=,100000.0,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells by FMP assay,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007.0,50.0,19.0,"Jensen AA, Zlotos DP, Liljefors T",,445995.0,DTCT0023221,2125523,DTCC00457678,2052137,23555,4.0,424,44427860,CC=CC[N+]12CCC3C1CC4C5C3N(C6C7C8CC9C1(C7N(C5OCC=C4C2)C2=CC=CC=C21)CC[N+]9(CC8=CCO6)CC=CC)C1=CC=CC=C1.[Br-].[Br-],CC=CC[N+]12CCC3C4C5C(CC31)C(=CCOC5N1c3ccccc3C35CC[N+]6(CC=CC)CC7=CCOC(C(C7CC36)C15)N4c1ccccc1)C2
CHEMBL231047,P46098,TOXIFERINE,UAMHUVZCGJSLHZ-ICRMOYGQSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904.0,IC50,>,100000.0,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells by FMP assay,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007.0,50.0,19.0,"Jensen AA, Zlotos DP, Liljefors T",,445995.0,DTCT0023221,2125490,DTCC00457693,127806,23555,4.0,425,44427885,C[N+]12CCC34C1CC(C(=CCO)C2)C5=CN6C7C(=CN(C53)C8=CC=CC=C48)C9CC1C7(CC[N+]1(CC9=CCO)C)C1=CC=CC=C16.[Cl-].[Cl-],C[N+]12CCC34c5ccccc5N5C=C6C7CC8C9(CC[N+]8(C)CC7=CCO)c7ccccc7N(C=C(C(CC31)C(=CCO)C2)C54)C69
CHEMBL231047,P46098,TOXIFERINE,UAMHUVZCGJSLHZ-ICRMOYGQSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904.0,IC50,>,100000.0,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells by FMP assay,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007.0,50.0,19.0,"Jensen AA, Zlotos DP, Liljefors T",,445995.0,DTCT0023221,2125491,DTCC00457693,127806,23555,4.0,425,44427885,C[N+]12CCC34C1CC(C(=CCO)C2)C5=CN6C7C(=CN(C53)C8=CC=CC=C48)C9CC1C7(CC[N+]1(CC9=CCO)C)C1=CC=CC=C16.[Cl-].[Cl-],C[N+]12CCC34c5ccccc5N5C=C6C7CC8C9(CC[N+]8(C)CC7=CCO)c7ccccc7N(C=C(C(CC31)C(=CCO)C2)C54)C69
CHEMBL231056,P46098,,MBYMMLFMGIPHJE-CGYIOGRBSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904.0,IC50,=,3981.07,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells by FMP assay,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007.0,50.0,19.0,"Jensen AA, Zlotos DP, Liljefors T",,445995.0,DTCT0023221,2125519,DTCC00457680,924516,23555,5.40000018605658,426,44427864,C1CC=CC(C1)[N+]23CCC4C2CC5C6C4N(C7C8C9CC1C2(C8N(C6OCC=C5C3)C3=CC=CC=C32)CC[N+]1(CC9=CCO7)C1CCCC=C1)C1=CC=CC=C1.[Br-].[Br-],C1=CC([N+]23CCC4C5C6C(CC42)C(=CCOC6N2c4ccccc4C46CC[N+]7(C8C=CCCC8)CC8=CCOC(C(C8CC47)C26)N5c2ccccc2)C3)CCC1
CHEMBL231056,P46098,,MBYMMLFMGIPHJE-CGYIOGRBSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904.0,IC50,=,4400.0,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells by FMP assay,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007.0,50.0,19.0,"Jensen AA, Zlotos DP, Liljefors T",,445995.0,DTCT0023221,2125518,DTCC00457680,924516,23555,5.356547323513812,426,44427864,C1CC=CC(C1)[N+]23CCC4C2CC5C6C4N(C7C8C9CC1C2(C8N(C6OCC=C5C3)C3=CC=CC=C32)CC[N+]1(CC9=CCO7)C1CCCC=C1)C1=CC=CC=C1.[Br-].[Br-],C1=CC([N+]23CCC4C5C6C(CC42)C(=CCOC6N2c4ccccc4C46CC[N+]7(C8C=CCCC8)CC8=CCOC(C(C8CC47)C26)N5c2ccccc2)C3)CCC1
CHEMBL2332488,P46098,,RQAGIIPBHMAHTO-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,23414838.0,IC50,=,19000.0,NM,,,,,,,,,,,,,,Inhibition of 5HT3 receptor (unknown origin),,Discovery of a novel series of quinolone a7 nicotinic acetylcholine receptor agonists.,Bioorg. Med. Chem. Lett.,2013.0,23.0,6.0,"McDonald IM, Mate RA, Zusi FC, Huang H, Post-Munson DJ, Ferrante MA, Gallagher L, Bertekap RL, Knox RJ, Robertson BJ, Harden DG, Morgan DG, Lodge NJ, Dworetzky SI, Olson RE, Macor JE",,943354.0,DTCT0023221,11831081,DTCC01346119,1515397,54050,4.721246399047171,430,23332842,CN(C)CCCN1C2=CC=CC=C2C(=C(C1=O)C#N)C3=CC=CC=C3,CN(C)CCCn1c(=O)c(C#N)c(-c2ccccc2)c2ccccc21
CHEMBL244561,P46098,,FPNPHDMTUDVXEY-ITAXXUCMSA-M,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904.0,IC50,=,30000.0,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells by FMP assay,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007.0,50.0,19.0,"Jensen AA, Zlotos DP, Liljefors T",,445995.0,DTCT0023221,2125526,DTCC00457676,1410573,23555,4.522878745280337,488,44427856,C=CC[N+]12CCC3C1CC4C5C3N(C6C7C8CC9C1(C7N(C5OCC=C4C2)C2=CC=CC=C21)CCN9CC8=CCO6)C1=CC=CC=C1.[Br-],C=CC[N+]12CCC3C4C5C(CC31)C(=CCOC5N1c3ccccc3C35CCN6CC7=CCOC(C(C7CC63)C15)N4c1ccccc1)C2
CHEMBL244561,P46098,,FPNPHDMTUDVXEY-ITAXXUCMSA-M,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904.0,IC50,=,31622.78,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells by FMP assay,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007.0,50.0,19.0,"Jensen AA, Zlotos DP, Liljefors T",,445995.0,DTCT0023221,2125527,DTCC00457676,1410573,23555,4.499999953328896,488,44427856,C=CC[N+]12CCC3C1CC4C5C3N(C6C7C8CC9C1(C7N(C5OCC=C4C2)C2=CC=CC=C21)CCN9CC8=CCO6)C1=CC=CC=C1.[Br-],C=CC[N+]12CCC3C4C5C(CC31)C(=CCOC5N1c3ccccc3C35CCN6CC7=CCOC(C(C7CC63)C15)N4c1ccccc1)C2
CHEMBL250699,P46098,A-803467,VHKBTPQDHDSBSP-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17483457.0,IC50,>,10000.0,NM,,,,,,,,,,,,,,Displacement of [3H]BRL43694 from 5HT3 receptor,,"A-803467, a potent and selective Nav1.8 sodium channel blocker, attenuates neuropathic and inflammatory pain in the rat.",Proc. Natl. Acad. Sci. U.S.A.,2007.0,104.0,20.0,"Jarvis MF, Honore P, Shieh CC, Chapman M, Joshi S, Zhang XF, Kort M, Carroll W, Marron B, Atkinson R, Thomas J, Liu D, Krambis M, Liu Y, McGaraughty S, Chu K, Roeloffs R, Zhong C, Mikusa JP, Hernandez G, Gauvin D, Wade C, Zhu C, Pai M, Scanio M, Shi L, Drizin I, Gregg R, Matulenko M, Hakeem A, Gross M, Johnson M, Marsh K, Wagoner PK, Sullivan JP, Faltynek CR, Krafte DS",,466569.0,DTCT0023221,2351663,DTCC00003813,310509,25480,5.0,491,16038374,COC1=CC(=CC(=C1)NC(=O)C2=CC=C(O2)C3=CC=C(C=C3)Cl)OC,COc1cc(NC(=O)c2ccc(-c3ccc(Cl)cc3)o2)cc(OC)c1
CHEMBL292779,P46098,L-775606,ZUTQCPBDRJBADG-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,9357515.0,IC50,>,10000.0,NM,,,,,,,,,,,,,,Compound was evaluated for the affinity at 5-hydroxytryptamine 3 receptor,,"Selective, orally active 5-HT1D receptor agonists as potential antimigraine agents.",J. Med. Chem.,1997.0,40.0,22.0,"MacLeod AM, Street LJ, Reeve AJ, Jelley RA, Sternfeld F, Beer MS, Stanton JA, Watt AP, Rathbone D, Matassa VG",,3459.0,DTCT0023221,729031,DTCC01740766,1240895,14385,5.0,516,6426760,C1CN(CCN1CCCC2=CNC3=C2C=C(C=C3)N4C=NN=C4)CCC5=CC(=CC=C5)F,Fc1cccc(CCN2CCN(CCCc3c[nH]c4ccc(-n5cnnc5)cc34)CC2)c1
CHEMBL293405,P46098,,SYMHUEFSSMBHJA-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22589534.0,IC50,=,100000.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14713992,DTCC00215839,2099448,68163,4.0,517,74820,CC1=C2C(=NC=N2)N=CN1,Cc1[nH]cnc2ncnc1-2
CHEMBL3216651,P46098,,KWSJSWCQZPEIPC-LQVXLWKRSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,9182127.0,IC50,>,100000.0,NM,,,,,,,,,,,,,,Displacement of radioligand from 5HT3 receptor by liquid scintillation spectrometry,,"Perhydrogenation of tabersonine, ans Aspidiosperma indole alkaloid.",J. Nat. Prod.,1997.0,60.0,4.0,"Lewin G, Schaeffer C, Dacquet C",,549546.0,DTCT0023221,2539168,DTCC01464065,1788318,27062,4.0,542,90664904,CCC12CCCN3C1C4(CC3)C5CCCCC5NC4C(C2)C(=O)OC.Cl.Cl,CCC12CCCN3CCC4(C5CCCCC5NC4C(C(=O)OC)C1)C32
CHEMBL364005,P46098,,BPPGPYJBCVXILI-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,16055331.0,IC50,=,34.0,NM,,cell_based,,,,,,,,,,,,Inhibitory activity against 5-hydroxytryptamine 3 receptor expressed in NG 108 cells,,"2-Alkyl-3-(1,2,3,6-tetrahydropyridin-4-yl)-1H-indoles as novel 5-HT6 receptor agonists.",Bioorg. Med. Chem. Lett.,2005.0,15.0,19.0,"Mattsson C, Sonesson C, Sandahl A, Greiner HE, Gassen M, Plaschke J, Leibrock J, Böttcher H",,321408.0,DTCT0023221,1847955,DTCC00405036,1113810,19721,7.468521082957745,613,10131112,CC1=C(C2=C(N1)C=CC(=C2)Cl)C3=CCNCC3,Cc1[nH]c2ccc(Cl)cc2c1C1=CCNCC1
CHEMBL374351,P46098,KKHT-10103,WHHXYDWPIRKEHF-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19447040.0,IC50,=,57000.0,NM,,,,,,,,,,,,,,Antagonist activity at 5HT3A receptor expressed in Xenopus oocyte,,Quinazolindione derivatives as potent 5-HT3A receptor antagonists.,Bioorg. Med. Chem.,2009.0,17.0,13.0,"Lee BH, Choi MJ, Jo MN, Seo HJ, Nah SY, Cho YS, Nam G, Pae AN, Rhim H, Choo H",,578446.0,DTCT0023221,2887673,DTCC00002551,921018,34988,4.2441251443275085,662,44422208,C1COCCN1CCNC(=O)C2=CC3=C(C=C2)C(=O)N(C(=O)N3)C4=CC=C(C=C4)F,O=C(NCCN1CCOCC1)c1ccc2c(=O)n(-c3ccc(F)cc3)c(=O)[nH]c2c1
CHEMBL376324,P46098,,BJPAAUARTYANJL-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,16971122.0,IC50,=,275.0,NM,,,,,,,,,,,,,,Inhibition of 5HT3 receptor,,Inhibitors of unactivated p38 MAP kinase.,Bioorg. Med. Chem. Lett.,2006.0,16.0,23.0,"Bullington J, Argentieri D, Averill K, Carter D, Cavender D, Fahmy B, Fan X, Hall D, Heintzelman G, Jackson P, Leung WP, Li X, Ling P, Olini G, Razler T, Reuman M, Rupert K, Russell R, Siekierka J, Wadsworth S, Wolff R, Xiang B, Zhang YM",,424582.0,DTCT0023221,2013813,DTCC00440693,1102639,21793,6.560667306169737,663,44419820,CN1C(=C(C(=C1N2CCNCC2)C3=CC=NC=C3)C4=CC=C(C=C4)F)C(=O)OC,COC(=O)c1c(-c2ccc(F)cc2)c(-c2ccncc2)c(N2CCNCC2)n1C
CHEMBL376596,P46098,KKHT-20818,PRICKWSOIKQPFF-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19447040.0,IC50,=,4800.0,NM,,,,,,,,,,,,,,Antagonist activity at 5HT3A receptor expressed in Xenopus oocyte,,Quinazolindione derivatives as potent 5-HT3A receptor antagonists.,Bioorg. Med. Chem.,2009.0,17.0,13.0,"Lee BH, Choi MJ, Jo MN, Seo HJ, Nah SY, Cho YS, Nam G, Pae AN, Rhim H, Choo H",,578446.0,DTCT0023221,2885918,DTCC00002562,1983565,34988,5.318758762624412,664,16066792,CCC1CCCCN1CCCNC(=O)C2=CC3=C(C=C2)C(=O)N(C(=O)N3)CC4=CC=C(C=C4)Cl,CCC1CCCCN1CCCNC(=O)c1ccc2c(=O)n(Cc3ccc(Cl)cc3)c(=O)[nH]c2c1
CHEMBL378349,P46098,,AFLJKKMTBWNZFE-AWEZNQCLSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21919481.0,IC50,=,188.0,NM,,,,,,,,,,,,,,Inhibition of 5HT3 receptor,,Discovery and development of a7 nicotinic acetylcholine receptor modulators.,J. Med. Chem.,2011.0,54.0,23.0,"Mazurov AA, Speake JD, Yohannes D",,851149.0,DTCT0023221,11361460,DTCC00427657,835012,50968,6.72584215073632,665,11543786,C1CN2CCC1C(C2)NC(=O)C3=CC4=C(C=C3)C=CS4,O=C(NC1CN2CCC1CC2)c1ccc2ccsc2c1
CHEMBL378471,P46098,,CXDMUUBLDHSHNL-AWEZNQCLSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21919481.0,IC50,=,580.0,NM,,,,,,,,,,,,,,Inhibition of 5HT3 receptor,,Discovery and development of a7 nicotinic acetylcholine receptor modulators.,J. Med. Chem.,2011.0,54.0,23.0,"Mazurov AA, Speake JD, Yohannes D",,851149.0,DTCT0023221,11361470,DTCC00427682,1800122,50968,6.236572006437063,666,9943346,C1CN2CCC1C(C2)NC(=O)C3=CC4=C(C=C3)OC=C4,O=C(NC1CN2CCC1CC2)c1ccc2occc2c1
CHEMBL379302,P46098,,LGWFAAILRNJWJB-AWEZNQCLSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21919481.0,IC50,=,962.0,NM,,,,,,,,,,,,,,Inhibition of 5HT3 receptor,,Discovery and development of a7 nicotinic acetylcholine receptor modulators.,J. Med. Chem.,2011.0,54.0,23.0,"Mazurov AA, Speake JD, Yohannes D",,851149.0,DTCT0023221,11361465,DTCC00427560,931900,50968,6.016824927962187,667,10445840,C1CN2CCC1C(C2)NC(=O)C3=CC4=C(C=C3)C=CO4,O=C(NC1CN2CCC1CC2)c1ccc2ccoc2c1
CHEMBL382243,P46098,,YUIBGCSVGUWIHQ-UHFFFAOYSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904.0,IC50,>,100000.0,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells by FMP assay,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007.0,50.0,19.0,"Jensen AA, Zlotos DP, Liljefors T",,445995.0,DTCT0023221,2125496,DTCC00417396,730707,23555,4.0,668,44408895,C[N+](C)(C)CC1=C2CN3C(=C(C4=CC=CC=C43)C[N+](C)(C)C)CN2C5=CC=CC=C51.[I-].[I-],C[N+](C)(C)Cc1c2n(c3ccccc13)Cc1c(C[N+](C)(C)C)c3ccccc3n1C2
CHEMBL382243,P46098,,YUIBGCSVGUWIHQ-UHFFFAOYSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904.0,IC50,>,100000.0,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells by FMP assay,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007.0,50.0,19.0,"Jensen AA, Zlotos DP, Liljefors T",,445995.0,DTCT0023221,2125497,DTCC00417396,730707,23555,4.0,668,44408895,C[N+](C)(C)CC1=C2CN3C(=C(C4=CC=CC=C43)C[N+](C)(C)C)CN2C5=CC=CC=C51.[I-].[I-],C[N+](C)(C)Cc1c2n(c3ccccc13)Cc1c(C[N+](C)(C)C)c3ccccc3n1C2
CHEMBL388046,P46098,,PYVYQZKNFYHFNG-XSHQRCBMSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904.0,IC50,=,30000.0,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells by FMP assay,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007.0,50.0,19.0,"Jensen AA, Zlotos DP, Liljefors T",,445995.0,DTCT0023221,2125512,DTCC00457684,1247690,23555,4.522878745280337,671,44427870,C1C[N+]2(CC3=CCOC4C5C3CC2C1C5N(C6C7C8CC9C1(C7N4C2=CC=CC=C21)CC[N+]9(CC8=CCO6)CC1=CC=C(C=C1)Br)C1=CC=CC=C1)CC1=CC=C(C=C1)Br.[Br-].[Br-],Brc1ccc(C[N+]23CCC4C5C6C(CC42)C(=CCOC6N2c4ccccc4C46CC[N+]7(Cc8ccc(Br)cc8)CC8=CCOC(C(C8CC47)C26)N5c2ccccc2)C3)cc1
CHEMBL388046,P46098,,PYVYQZKNFYHFNG-XSHQRCBMSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904.0,IC50,=,31622.78,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells by FMP assay,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007.0,50.0,19.0,"Jensen AA, Zlotos DP, Liljefors T",,445995.0,DTCT0023221,2125513,DTCC00457684,1247690,23555,4.499999953328896,671,44427870,C1C[N+]2(CC3=CCOC4C5C3CC2C1C5N(C6C7C8CC9C1(C7N4C2=CC=CC=C21)CC[N+]9(CC8=CCO6)CC1=CC=C(C=C1)Br)C1=CC=CC=C1)CC1=CC=C(C=C1)Br.[Br-].[Br-],Brc1ccc(C[N+]23CCC4C5C6C(CC42)C(=CCOC6N2c4ccccc4C46CC[N+]7(Cc8ccc(Br)cc8)CC8=CCOC(C(C8CC47)C26)N5c2ccccc2)C3)cc1
CHEMBL388048,P46098,,VVWIDIIMLHNFOH-SBUQLOQDSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904.0,IC50,=,2500.0,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells by FMP assay,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007.0,50.0,19.0,"Jensen AA, Zlotos DP, Liljefors T",,445995.0,DTCT0023221,2125507,DTCC00457687,244447,23555,5.6020599913279625,673,44427876,C1CN2CC(=CCO)C3CC2C1C4C3=CN5C6C7C8CC9C6(CCN9CC8=CCOC7N4C1=CC=CC=C1)C1=CC=CC=C15,OCC=C1CN2CCC3C2CC1C1=CN2c4ccccc4C45CCN6CC7=CCOC(C(C7CC64)C25)N(c2ccccc2)C13
CHEMBL388048,P46098,,VVWIDIIMLHNFOH-SBUQLOQDSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904.0,IC50,=,2511.89,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells by FMP assay,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007.0,50.0,19.0,"Jensen AA, Zlotos DP, Liljefors T",,445995.0,DTCT0023221,2125508,DTCC00457687,244447,23555,5.59999938302362,673,44427876,C1CN2CC(=CCO)C3CC2C1C4C3=CN5C6C7C8CC9C6(CCN9CC8=CCOC7N4C1=CC=CC=C1)C1=CC=CC=C15,OCC=C1CN2CCC3C2CC1C1=CN2c4ccccc4C45CCN6CC7=CCOC(C(C7CC64)C25)N(c2ccccc2)C13
CHEMBL388401,P46098,KKHT-10318,VJRGAGPCQUZOLU-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19447040.0,IC50,=,7500.0,NM,,,,,,,,,,,,,,Antagonist activity at 5HT3A receptor expressed in Xenopus oocyte,,Quinazolindione derivatives as potent 5-HT3A receptor antagonists.,Bioorg. Med. Chem.,2009.0,17.0,13.0,"Lee BH, Choi MJ, Jo MN, Seo HJ, Nah SY, Cho YS, Nam G, Pae AN, Rhim H, Choo H",,578446.0,DTCT0023221,2887676,DTCC00002566,1276678,34988,5.1249387366083,674,44422402,C1CCN(C1)CCNC(=O)C2=CC3=C(C=C2)C(=O)N(C(=O)N3)CC4=CC=C(C=C4)Cl,O=C(NCCN1CCCC1)c1ccc2c(=O)n(Cc3ccc(Cl)cc3)c(=O)[nH]c2c1
CHEMBL389120,P46098,,MMIPHEFKLSFNNB-MWGLOKQDSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904.0,IC50,=,30000.0,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells by FMP assay,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007.0,50.0,19.0,"Jensen AA, Zlotos DP, Liljefors T",,445995.0,DTCT0023221,2125514,DTCC00457683,892666,23555,4.522878745280337,675,44427868,COC1=C(C=C(C=C1)C[N+]23CCC4C2CC5C6C4N(C7C8C9CC1C2(C8N(C6OCC=C5C3)C3=CC=CC=C32)CC[N+]1(CC9=CCO7)CC1=CC(=C(C=C1)OC)OC)C1=CC=CC=C1)OC.[Cl-].[Cl-],COc1ccc(C[N+]23CCC4C5C6C(CC42)C(=CCOC6N2c4ccccc4C46CC[N+]7(Cc8ccc(OC)c(OC)c8)CC8=CCOC(C(C8CC47)C26)N5c2ccccc2)C3)cc1OC
CHEMBL389120,P46098,,MMIPHEFKLSFNNB-MWGLOKQDSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904.0,IC50,=,31622.78,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells by FMP assay,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007.0,50.0,19.0,"Jensen AA, Zlotos DP, Liljefors T",,445995.0,DTCT0023221,2125515,DTCC00457683,892666,23555,4.499999953328896,675,44427868,COC1=C(C=C(C=C1)C[N+]23CCC4C2CC5C6C4N(C7C8C9CC1C2(C8N(C6OCC=C5C3)C3=CC=CC=C32)CC[N+]1(CC9=CCO7)CC1=CC(=C(C=C1)OC)OC)C1=CC=CC=C1)OC.[Cl-].[Cl-],COc1ccc(C[N+]23CCC4C5C6C(CC42)C(=CCOC6N2c4ccccc4C46CC[N+]7(Cc8ccc(OC)c(OC)c8)CC8=CCOC(C(C8CC47)C26)N5c2ccccc2)C3)cc1OC
CHEMBL390135,P46098,,FUSIITLPTACWMA-XYRKINJJSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904.0,IC50,=,100000.0,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells by FMP assay,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007.0,50.0,19.0,"Jensen AA, Zlotos DP, Liljefors T",,445995.0,DTCT0023221,2125524,DTCC00457677,1760292,23555,4.0,677,44427858,C=CC[N+]12CCC3C1CC4C5C3N(C6C7C8CC9C1(C7N(C5OCC=C4C2)C2=CC=CC=C21)CC[N+]9(CC8=CCO6)CC=C)C1=CC=CC=C1.[Br-].[Br-],C=CC[N+]12CCC3C4C5C(CC31)C(=CCOC5N1c3ccccc3C35CC[N+]6(CC=C)CC7=CCOC(C(C7CC36)C15)N4c1ccccc1)C2
CHEMBL390135,P46098,,FUSIITLPTACWMA-XYRKINJJSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904.0,IC50,=,100000.0,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells by FMP assay,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007.0,50.0,19.0,"Jensen AA, Zlotos DP, Liljefors T",,445995.0,DTCT0023221,2125525,DTCC00457677,1760292,23555,4.0,677,44427858,C=CC[N+]12CCC3C1CC4C5C3N(C6C7C8CC9C1(C7N(C5OCC=C4C2)C2=CC=CC=C21)CC[N+]9(CC8=CCO6)CC=C)C1=CC=CC=C1.[Br-].[Br-],C=CC[N+]12CCC3C4C5C(CC31)C(=CCOC5N1c3ccccc3C35CC[N+]6(CC=C)CC7=CCOC(C(C7CC36)C15)N4c1ccccc1)C2
CHEMBL395727,P46098,,VJSCAPXAYUYCDD-MBOLQDAKSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904.0,IC50,=,30000.0,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells by FMP assay,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007.0,50.0,19.0,"Jensen AA, Zlotos DP, Liljefors T",,445995.0,DTCT0023221,2125528,DTCC00457675,147879,23555,4.522878745280337,681,44427854,C[N+]12CCC3C1CC4C5C3N(C6C7C8CC9C1(C7N(C5OCC=C4C2)C2=CC=CC=C21)CC[N+]9(CC8=CCO6)C)C1=CC=CC=C1.[I-].[I-],C[N+]12CCC3C4C5C(CC31)C(=CCOC5N1c3ccccc3C35CC[N+]6(C)CC7=CCOC(C(C7CC36)C15)N4c1ccccc1)C2
CHEMBL395727,P46098,,VJSCAPXAYUYCDD-MBOLQDAKSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904.0,IC50,=,31622.78,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells by FMP assay,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007.0,50.0,19.0,"Jensen AA, Zlotos DP, Liljefors T",,445995.0,DTCT0023221,2125529,DTCC00457675,147879,23555,4.499999953328896,681,44427854,C[N+]12CCC3C1CC4C5C3N(C6C7C8CC9C1(C7N(C5OCC=C4C2)C2=CC=CC=C21)CC[N+]9(CC8=CCO6)C)C1=CC=CC=C1.[I-].[I-],C[N+]12CCC3C4C5C(CC31)C(=CCOC5N1c3ccccc3C35CC[N+]6(C)CC7=CCOC(C(C7CC36)C15)N4c1ccccc1)C2
CHEMBL395960,P46098,,UKZPDTRKIBHQLP-JKBBQUHLSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904.0,IC50,>,100000.0,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells by FMP assay,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007.0,50.0,19.0,"Jensen AA, Zlotos DP, Liljefors T",,445995.0,DTCT0023221,2125520,DTCC00457679,1889425,23555,4.0,682,44427862,CC(=O)OCC[N+]12CCC3C1CC4C5C3N(C6C7C8CC9C1(C7N(C5OCC=C4C2)C2=CC=CC=C21)CC[N+]9(CC8=CCO6)CCOC(=O)C)C1=CC=CC=C1.[Br-].[Br-],CC(=O)OCC[N+]12CCC3C4C5C(CC31)C(=CCOC5N1c3ccccc3C35CC[N+]6(CCOC(C)=O)CC7=CCOC(C(C7CC36)C15)N4c1ccccc1)C2
CHEMBL395960,P46098,,UKZPDTRKIBHQLP-JKBBQUHLSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904.0,IC50,>,100000.0,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells by FMP assay,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007.0,50.0,19.0,"Jensen AA, Zlotos DP, Liljefors T",,445995.0,DTCT0023221,2125521,DTCC00457679,1889425,23555,4.0,682,44427862,CC(=O)OCC[N+]12CCC3C1CC4C5C3N(C6C7C8CC9C1(C7N(C5OCC=C4C2)C2=CC=CC=C21)CC[N+]9(CC8=CCO6)CCOC(=O)C)C1=CC=CC=C1.[Br-].[Br-],CC(=O)OCC[N+]12CCC3C4C5C(CC31)C(=CCOC5N1c3ccccc3C35CC[N+]6(CCOC(C)=O)CC7=CCOC(C(C7CC36)C15)N4c1ccccc1)C2
CHEMBL396705,P46098,,RYIMMAUZEHWVRP-JJDXUFKPSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904.0,IC50,=,100000.0,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells by FMP assay,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007.0,50.0,19.0,"Jensen AA, Zlotos DP, Liljefors T",,445995.0,DTCT0023221,2125516,DTCC00457681,601373,23555,4.0,683,44427866,C1C[N+]2(CC3=CCOC4C5C3CC2C1C5N(C6C7C8CC9C1(C7N4C2=CC=CC=C21)CC[N+]9(CC8=CCO6)CC1=CC=CC=C1)C1=CC=CC=C1)CC1=CC=CC=C1.[Br-].[Br-],C1=C2C[N+]3(Cc4ccccc4)CCC4C5C(C2CC43)C(OC1)N1c2ccccc2C23CC[N+]4(Cc6ccccc6)CC6=CCOC(C(C6CC24)C13)N5c1ccccc1
CHEMBL396705,P46098,,RYIMMAUZEHWVRP-JJDXUFKPSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904.0,IC50,=,100000.0,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells by FMP assay,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007.0,50.0,19.0,"Jensen AA, Zlotos DP, Liljefors T",,445995.0,DTCT0023221,2125517,DTCC00457681,601373,23555,4.0,683,44427866,C1C[N+]2(CC3=CCOC4C5C3CC2C1C5N(C6C7C8CC9C1(C7N4C2=CC=CC=C21)CC[N+]9(CC8=CCO6)CC1=CC=CC=C1)C1=CC=CC=C1)CC1=CC=CC=C1.[Br-].[Br-],C1=C2C[N+]3(Cc4ccccc4)CCC4C5C(C2CC43)C(OC1)N1c2ccccc2C23CC[N+]4(Cc6ccccc6)CC6=CCOC(C(C6CC24)C13)N5c1ccccc1
CHEMBL397434,P46098,,ULIQGBPQLPCTAJ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22589534.0,IC50,=,30000.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14718823,DTCC00455328,2101764,68163,4.522878745280337,685,93558,C1=CC=C(C=C1)CSC2=NC=NC3=C2NC=N3,c1ccc(CSc2ncnc3nc[nH]c23)cc1
CHEMBL407391,P46098,DIMETHYLADENINE,BVIAOQMSVZHOJM-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,22589534.0,IC50,=,100000.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023221,14718000,DTCC00494965,2101324,68163,4.0,694,3134,CN(C)C1=NC=NC2=C1NC=N2,CN(C)c1ncnc2nc[nH]c12
CHEMBL415568,P46098,,SJGFHXJCUGAPEE-FSEYQHDASA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904.0,IC50,=,3981.07,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells by FMP assay,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007.0,50.0,19.0,"Jensen AA, Zlotos DP, Liljefors T",,445995.0,DTCT0023221,2125506,DTCC00457688,1889427,23555,5.40000018605658,698,44427877,C[N+]12CCC3C1CC(C(=CCO)C2)C4=CN5C6C7C8CC9C6(CC[N+]9(CC8=CCOC7N(C34)C1=CC=CC=C1)C)C1=CC=CC=C15.[I-].[I-],C[N+]12CCC3C4C(=CN5c6ccccc6C67CC[N+]8(C)CC9=CCOC(C(C9CC68)C57)N4c4ccccc4)C(CC31)C(=CCO)C2
CHEMBL415568,P46098,,SJGFHXJCUGAPEE-FSEYQHDASA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904.0,IC50,=,4200.0,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells by FMP assay,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007.0,50.0,19.0,"Jensen AA, Zlotos DP, Liljefors T",,445995.0,DTCT0023221,2125505,DTCC00457688,1889427,23555,5.376750709602099,698,44427877,C[N+]12CCC3C1CC(C(=CCO)C2)C4=CN5C6C7C8CC9C6(CC[N+]9(CC8=CCOC7N(C34)C1=CC=CC=C1)C)C1=CC=CC=C15.[I-].[I-],C[N+]12CCC3C4C(=CN5c6ccccc6C67CC[N+]8(C)CC9=CCOC(C(C9CC68)C57)N4c4ccccc4)C(CC31)C(=CCO)C2
CHEMBL415569,P46098,,HIKALAMHAXPLDW-RCCNGQCQSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904.0,IC50,=,30000.0,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells by FMP assay,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007.0,50.0,19.0,"Jensen AA, Zlotos DP, Liljefors T",,445995.0,DTCT0023221,2125503,DTCC00457689,1474801,23555,4.522878745280337,699,44427879,C1CC=CC(C1)[N+]23CCC4C2CC(C(=CCO)C3)C5=CN6C7C8C9CC1C7(CC[N+]1(CC9=CCOC8N(C45)C1=CC=CC=C1)C1CCCC=C1)C1=CC=CC=C16.[Br-].[Br-],OCC=C1C[N+]2(C3C=CCCC3)CCC3C4C(=CN5c6ccccc6C67CC[N+]8(C9C=CCCC9)CC9=CCOC(C(C9CC68)C57)N4c4ccccc4)C1CC32
CHEMBL415569,P46098,,HIKALAMHAXPLDW-RCCNGQCQSA-L,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,17722904.0,IC50,=,31622.78,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human 5HT3A receptor expressed in HEK293 cells by FMP assay,,Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2007.0,50.0,19.0,"Jensen AA, Zlotos DP, Liljefors T",,445995.0,DTCT0023221,2125504,DTCC00457689,1474801,23555,4.499999953328896,699,44427879,C1CC=CC(C1)[N+]23CCC4C2CC(C(=CCO)C3)C5=CN6C7C8C9CC1C7(CC[N+]1(CC9=CCOC8N(C45)C1=CC=CC=C1)C1CCCC=C1)C1=CC=CC=C16.[Br-].[Br-],OCC=C1C[N+]2(C3C=CCCC3)CCC3C4C(=CN5c6ccccc6C67CC[N+]8(C9C=CCCC9)CC9=CCOC(C(C9CC68)C57)N4c4ccccc4)C1CC32
CHEMBL453023,P46098,,IAORVHGBICJISE-STYPWORHSA-M,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,9182127.0,IC50,>,100000.0,NM,,,,,,,,,,,,,,Displacement of radioligand from 5HT3 receptor by liquid scintillation spectrometry,,"Perhydrogenation of tabersonine, ans Aspidiosperma indole alkaloid.",J. Nat. Prod.,1997.0,60.0,4.0,"Lewin G, Schaeffer C, Dacquet C",,549546.0,DTCT0023221,2539167,DTCC00113358,597145,27062,4.0,710,44559406,CCC12CCCN3C1C4(CC3)C5CCCCC5NC4C(C2)C(=O)[O-].[Na+],CCC12CCCN3CCC4(C5CCCCC5NC4C(C(=O)[O-])C1)C32
CHEMBL454407,P46098,,VKXYLXZLODSKCD-QZTJIDSGSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19208472.0,IC50,=,251188.64,NM,,,,,,,,,,,,,,Antagonist activity at human 5HT3 receptor by calcium influx assay,,Gamma-lactams--a novel scaffold for highly potent and selective alpha 7 nicotinic acetylcholine receptor agonists.,Bioorg. Med. Chem. Lett.,2009.0,19.0,5.0,"Enz A, Feuerbach D, Frederiksen MU, Gentsch C, Hurth K, Müller W, Nozulak J, Roy BL",,566267.0,DTCT0023221,2473366,DTCC00517737,1841786,32916,3.6000000054478725,712,42631007,CN1C(CC(C1=O)CN2CCCCC2)C#CC3=CC=CC=C3,CN1C(=O)C(CN2CCCCC2)CC1C#Cc1ccccc1
CHEMBL459689,P46098,,NBYYGODJBZAJJF-WOJBJXKFSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19208472.0,IC50,=,25118.86,NM,,,,,,,,,,,,,,Antagonist activity at human 5HT3 receptor by calcium influx assay,,Gamma-lactams--a novel scaffold for highly potent and selective alpha 7 nicotinic acetylcholine receptor agonists.,Bioorg. Med. Chem. Lett.,2009.0,19.0,5.0,"Enz A, Feuerbach D, Frederiksen MU, Gentsch C, Hurth K, Müller W, Nozulak J, Roy BL",,566267.0,DTCT0023221,2473367,DTCC00517852,941322,32916,4.600000074606178,714,44564662,CN1C=CC2=C1C=CC(=C2)C#CC3CC(C(=O)N3C)CN4CCCCC4,CN1C(=O)C(CN2CCCCC2)CC1C#Cc1ccc2c(ccn2C)c1
CHEMBL459900,P46098,,KNSUADXKFTZSIZ-RTBURBONSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19208472.0,IC50,=,100000.0,NM,,,,,,,,,,,,,,Antagonist activity at human 5HT3 receptor by calcium influx assay,,Gamma-lactams--a novel scaffold for highly potent and selective alpha 7 nicotinic acetylcholine receptor agonists.,Bioorg. Med. Chem. Lett.,2009.0,19.0,5.0,"Enz A, Feuerbach D, Frederiksen MU, Gentsch C, Hurth K, Müller W, Nozulak J, Roy BL",,566267.0,DTCT0023221,2473368,DTCC00517853,164502,32916,4.0,716,44157061,CN1C(CC(C1=O)CN2CCCCC2)C#CC3=CC4=C(C=C3)OC=C4,CN1C(=O)C(CN2CCCCC2)CC1C#Cc1ccc2occc2c1
CHEMBL46,P46098,ONDANSETRON,FELGMEQIXOGIFQ-UHFFFAOYSA-N,4,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21486038.0,IC50,=,0.09,NM,,cell_based,,,,,,,,,,,Oocytes,Antagonist activity at human 5HT3A receptor expressed in xenopus oocytes assessed as inhibition of 5HT-induced effect by electrophysiological method,,"Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): A Novel Multimodal Compound for the Treatment of Major Depressive Disorder.",J. Med. Chem.,2011.0,54.0,9.0,"Bang-Andersen B, Ruhland T, Jørgensen M, Smith G, Frederiksen K, Jensen KG, Zhong H, Nielsen SM, Hogg S, Mørk A, Stensbøl TB",,880244.0,DTCT0023221,11460193,DTCC00134875,297651,51828,10.045757490560675,717,4595,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,Cc1nccn1CC1CCc2c(c3ccccc3n2C)C1=O
CHEMBL470432,P46098,,FZGWDCDUMFWUEO-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19261477.0,IC50,=,6.92,NM,,,,,,,,,,,,,,Displacement of [3H]granisetron from human recombinant 5HT3 receptor,,Novel antagonists of serotonin-4 receptors: synthesis and biological evaluation of pyrrolothienopyrazines.,Bioorg. Med. Chem.,2009.0,17.0,6.0,"Lemaître S, Lepailleur A, Bureau R, Butt-Gueulle S, Lelong-Boulouard V, Duchatelle P, Boulouard M, Dumuis A, Daveu C, Lezoualc'h F, Pfeiffer B, Dauphin F, Rault S",,564583.0,DTCT0023221,2613037,DTCC00570224,1082935,33265,8.159893905543242,723,42636941,CCCN1CCC(CC1)COC2=NC3=C(C(=CS3)C)N4C2=CC=C4,CCCN1CCC(COc2nc3scc(C)c3n3cccc23)CC1
CHEMBL470432,P46098,,FZGWDCDUMFWUEO-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19261477.0,IC50,=,385.0,NM,,cell_based,,,,,,,,,,,NG108-15,Antagonist activity at 5HT3 receptor in hybrid NG108-15 cells assessed as inhibition of 5HT-induced current by electrophysiology,,Novel antagonists of serotonin-4 receptors: synthesis and biological evaluation of pyrrolothienopyrazines.,Bioorg. Med. Chem.,2009.0,17.0,6.0,"Lemaître S, Lepailleur A, Bureau R, Butt-Gueulle S, Lelong-Boulouard V, Duchatelle P, Boulouard M, Dumuis A, Daveu C, Lezoualc'h F, Pfeiffer B, Dauphin F, Rault S",,564575.0,DTCT0023221,2613019,DTCC00570224,1082935,33265,6.414539270491499,723,42636941,CCCN1CCC(CC1)COC2=NC3=C(C(=CS3)C)N4C2=CC=C4,CCCN1CCC(COc2nc3scc(C)c3n3cccc23)CC1
CHEMBL471663,P46098,,CZPMNOSNQHHGTD-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19261477.0,IC50,>,10000.0,NM,,,,,,,,,,,,,,Displacement of [3H]granisetron from human recombinant 5HT3 receptor,,Novel antagonists of serotonin-4 receptors: synthesis and biological evaluation of pyrrolothienopyrazines.,Bioorg. Med. Chem.,2009.0,17.0,6.0,"Lemaître S, Lepailleur A, Bureau R, Butt-Gueulle S, Lelong-Boulouard V, Duchatelle P, Boulouard M, Dumuis A, Daveu C, Lezoualc'h F, Pfeiffer B, Dauphin F, Rault S",,564583.0,DTCT0023221,2613734,DTCC00569998,371836,33265,5.0,725,44592109,CCCCN1CCC(CC1)COC2=NC3=C(N4C2=CC=C4)SC=C3,CCCCN1CCC(COc2nc3ccsc3n3cccc23)CC1
CHEMBL499536,P46098,,HQYLURGLNKLOQJ-XHDPSFHLSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19208472.0,IC50,=,19952.62,NM,,,,,,,,,,,,,,Antagonist activity at human 5HT3 receptor by calcium influx assay,,Gamma-lactams--a novel scaffold for highly potent and selective alpha 7 nicotinic acetylcholine receptor agonists.,Bioorg. Med. Chem. Lett.,2009.0,19.0,5.0,"Enz A, Feuerbach D, Frederiksen MU, Gentsch C, Hurth K, Müller W, Nozulak J, Roy BL",,566267.0,DTCT0023221,2473370,DTCC00517855,1555907,32916,4.70000006855703,759,11679149,CC(C1=CC=CC=C1F)OC(=O)NC2CN3CCC2CC3,CC(OC(=O)NC1CN2CCC1CC2)c1ccccc1F
CHEMBL503427,P46098,,BSAYMXGAHRLDCA-RTBURBONSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19208472.0,IC50,=,50118.72,NM,,,,,,,,,,,,,,Antagonist activity at human 5HT3 receptor by calcium influx assay,,Gamma-lactams--a novel scaffold for highly potent and selective alpha 7 nicotinic acetylcholine receptor agonists.,Bioorg. Med. Chem. Lett.,2009.0,19.0,5.0,"Enz A, Feuerbach D, Frederiksen MU, Gentsch C, Hurth K, Müller W, Nozulak J, Roy BL",,566267.0,DTCT0023221,2473369,DTCC00517854,132100,32916,4.300000029139089,762,44564663,CN1C(CC(C1=O)CN2CCCCC2)C#CC3=CC4=C(C=C3)OCC4,CN1C(=O)C(CN2CCCCC2)CC1C#Cc1ccc2c(c1)CCO2
CHEMBL509387,P46098,(-)-TABERSONINE HCL,BFVXDLZRORZNHX-OCIDDWSYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,9182127.0,IC50,>,100000.0,NM,,,,,,,,,,,,,,Displacement of radioligand from 5HT3 receptor by liquid scintillation spectrometry,,"Perhydrogenation of tabersonine, ans Aspidiosperma indole alkaloid.",J. Nat. Prod.,1997.0,60.0,4.0,"Lewin G, Schaeffer C, Dacquet C",,549546.0,DTCT0023221,2539166,DTCC00004852,1406207,27062,4.0,763,44559404,CCC12CCCN3C1C4(CC3)C5=CC=CC=C5NC4=C(C2)C(=O)OC.Cl,CCC12CCCN3CCC4(C(=C(C(=O)OC)C1)Nc1ccccc14)C32
CHEMBL511312,P46098,,RZFPSYUVZCCIFI-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19261477.0,IC50,>,1000.0,NM,,,,,,,,,,,,,,Displacement of [3H]granisetron from human recombinant 5HT3 receptor,,Novel antagonists of serotonin-4 receptors: synthesis and biological evaluation of pyrrolothienopyrazines.,Bioorg. Med. Chem.,2009.0,17.0,6.0,"Lemaître S, Lepailleur A, Bureau R, Butt-Gueulle S, Lelong-Boulouard V, Duchatelle P, Boulouard M, Dumuis A, Daveu C, Lezoualc'h F, Pfeiffer B, Dauphin F, Rault S",,564583.0,DTCT0023221,2613740,DTCC00569996,371835,33265,6.0,766,9861687,CCN1CCC(CC1)COC2=NC3=C(N4C2=CC=C4)SC=C3,CCN1CCC(COc2nc3ccsc3n3cccc23)CC1
CHEMBL54720,P46098,,QYWDOJXSLBBWLE-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19261477.0,IC50,=,1.41,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]granisetron form 5HT3 receptor in hybrid NG180-15 cells,,Novel antagonists of serotonin-4 receptors: synthesis and biological evaluation of pyrrolothienopyrazines.,Bioorg. Med. Chem.,2009.0,17.0,6.0,"Lemaître S, Lepailleur A, Bureau R, Butt-Gueulle S, Lelong-Boulouard V, Duchatelle P, Boulouard M, Dumuis A, Daveu C, Lezoualc'h F, Pfeiffer B, Dauphin F, Rault S",,564556.0,DTCT0023221,2613762,DTCC00197722,240858,33265,8.85078088734462,779,9863146,C1CN(CCN1CC2=CC=CC=C2)C3=NC4=C(N5C3=CC=C5)SC=C4,c1ccc(CN2CCN(c3nc4ccsc4n4cccc34)CC2)cc1
CHEMBL559478,P46098,SSR180711,RXLOZRCLQMJJLC-UHFFFAOYSA-N,2,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19576766.0,IC50,>,3160.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]LY278584 from human 5HT3 receptor expressed in HEK293 cells,,"Synthesis and SAR studies of 1,4-diazabicyclo[3.2.2]nonane phenyl carbamates--subtype selective, high affinity alpha7 nicotinic acetylcholine receptor agonists.",Bioorg. Med. Chem. Lett.,2009.0,19.0,16.0,"O'Donnell CJ, Peng L, O'Neill BT, Arnold EP, Mather RJ, Sands SB, Shrikhande A, Lebel LA, Spracklin DK, Nedza FM",,582492.0,DTCT0023221,2914150,DTCC00583548,985720,35190,5.5003129173815966,785,9797360,C1CN2CCC1N(CC2)C(=O)OC3=CC=C(C=C3)Br,O=C(Oc1ccc(Br)cc1)N1CCN2CCC1CC2
CHEMBL564850,P46098,,MQZFLDZRBIKMGM-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19576766.0,IC50,>,3160.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]LY278584 from human 5HT3 receptor expressed in HEK293 cells,,"Synthesis and SAR studies of 1,4-diazabicyclo[3.2.2]nonane phenyl carbamates--subtype selective, high affinity alpha7 nicotinic acetylcholine receptor agonists.",Bioorg. Med. Chem. Lett.,2009.0,19.0,16.0,"O'Donnell CJ, Peng L, O'Neill BT, Arnold EP, Mather RJ, Sands SB, Shrikhande A, Lebel LA, Spracklin DK, Nedza FM",,582492.0,DTCT0023221,2914151,DTCC00586605,79685,35190,5.5003129173815966,789,9879256,C1CN2CCC1N(CC2)C(=O)OC3=CC4=CC=CC=C4C=C3,O=C(Oc1ccc2ccccc2c1)N1CCN2CCC1CC2
CHEMBL569357,P46098,,HFOUMBDMIJJHCK-OSPHWJPCSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19700325.0,IC50,=,3100.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human recombinant 5-HT3 receptor expressed in HEK293 cells,,mu-Opioid/5-HT4 dual pharmacologically active agents-efforts towards an effective opioid analgesic with less GI and respiratory side effects (Part I).,Bioorg. Med. Chem. Lett.,2009.0,19.0,19.0,"Shao L, Wang F, Hewitt MC, Barberich TJ",,598654.0,DTCT0023221,3114455,DTCC00604510,1039093,36218,5.508638306165727,794,45485614,CN(CCNC(=O)C1=CC(=C(C=C1OC)N)Cl)CC2CCCCC2(C3=CC(=CC=C3)O)O,COc1cc(N)c(Cl)cc1C(=O)NCCN(C)CC1CCCCC1(O)c1cccc(O)c1
CHEMBL570487,P46098,,POJMJIIKSJRQPV-UBMARQKXSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19700325.0,IC50,=,1700.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human recombinant 5-HT3 receptor expressed in HEK293 cells,,mu-Opioid/5-HT4 dual pharmacologically active agents-efforts towards an effective opioid analgesic with less GI and respiratory side effects (Part I).,Bioorg. Med. Chem. Lett.,2009.0,19.0,19.0,"Shao L, Wang F, Hewitt MC, Barberich TJ",,598654.0,DTCT0023221,3114462,DTCC00604561,619033,36218,5.769551078621726,795,45485653,COC1CN(CCC1NC(=O)C2=CC(=C(C=C2OC)N)Cl)CC3CCCCC3(C4=CC(=CC=C4)OC)O,COc1cccc(C2(O)CCCCC2CN2CCC(NC(=O)c3cc(Cl)c(N)cc3OC)C(OC)C2)c1
CHEMBL570710,P46098,,SOEFWQWHKHCTLH-BIIVWMMYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19700325.0,IC50,=,1600.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human recombinant 5-HT3 receptor expressed in HEK293 cells,,mu-Opioid/5-HT4 dual pharmacologically active agents-efforts towards an effective opioid analgesic with less GI and respiratory side effects (Part I).,Bioorg. Med. Chem. Lett.,2009.0,19.0,19.0,"Shao L, Wang F, Hewitt MC, Barberich TJ",,598654.0,DTCT0023221,3114459,DTCC00604500,1874707,36218,5.795880017344075,796,45485604,COC1CN(CCC1NC(=O)C2=CC(=C(C=C2OC)N)Cl)CC3CCCCC3(C4=CC(=CC=C4)O)O,COc1cc(N)c(Cl)cc1C(=O)NC1CCN(CC2CCCCC2(O)c2cccc(O)c2)CC1OC
CHEMBL571799,P46098,,POJMJIIKSJRQPV-QZOFJNMOSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19700325.0,IC50,=,159.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human recombinant 5-HT3 receptor expressed in HEK293 cells,,mu-Opioid/5-HT4 dual pharmacologically active agents-efforts towards an effective opioid analgesic with less GI and respiratory side effects (Part I).,Bioorg. Med. Chem. Lett.,2009.0,19.0,19.0,"Shao L, Wang F, Hewitt MC, Barberich TJ",,598654.0,DTCT0023221,3114464,DTCC00604612,133045,36218,6.798602875679548,797,44626295,COC1CN(CCC1NC(=O)C2=CC(=C(C=C2OC)N)Cl)CC3CCCCC3(C4=CC(=CC=C4)OC)O,COc1cccc(C2(O)CCCCC2CN2CCC(NC(=O)c3cc(Cl)c(N)cc3OC)C(OC)C2)c1
CHEMBL572038,P46098,,OHGAQBAXUOYIOB-CJAUYULYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19700325.0,IC50,=,3500.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human recombinant 5-HT3 receptor expressed in HEK293 cells,,mu-Opioid/5-HT4 dual pharmacologically active agents-efforts towards an effective opioid analgesic with less GI and respiratory side effects (Part I).,Bioorg. Med. Chem. Lett.,2009.0,19.0,19.0,"Shao L, Wang F, Hewitt MC, Barberich TJ",,598654.0,DTCT0023221,3114453,DTCC00604452,165404,36218,5.455931955649724,798,45485563,CN(CCNC(=O)C1=CC(=C(C=C1OC)N)Cl)CC2CCCCC2(C3=CC(=CC=C3)OC)O,COc1cccc(C2(O)CCCCC2CN(C)CCNC(=O)c2cc(Cl)c(N)cc2OC)c1
CHEMBL572248,P46098,,HFOUMBDMIJJHCK-BXKMTCNYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19700325.0,IC50,=,2500.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human recombinant 5-HT3 receptor expressed in HEK293 cells,,mu-Opioid/5-HT4 dual pharmacologically active agents-efforts towards an effective opioid analgesic with less GI and respiratory side effects (Part I).,Bioorg. Med. Chem. Lett.,2009.0,19.0,19.0,"Shao L, Wang F, Hewitt MC, Barberich TJ",,598654.0,DTCT0023221,3114456,DTCC00604517,229795,36218,5.6020599913279625,799,45485619,CN(CCNC(=O)C1=CC(=C(C=C1OC)N)Cl)CC2CCCCC2(C3=CC(=CC=C3)O)O,COc1cc(N)c(Cl)cc1C(=O)NCCN(C)CC1CCCCC1(O)c1cccc(O)c1
CHEMBL572249,P46098,,SOEFWQWHKHCTLH-QJTHLVPVSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19700325.0,IC50,=,1400.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human recombinant 5-HT3 receptor expressed in HEK293 cells,,mu-Opioid/5-HT4 dual pharmacologically active agents-efforts towards an effective opioid analgesic with less GI and respiratory side effects (Part I).,Bioorg. Med. Chem. Lett.,2009.0,19.0,19.0,"Shao L, Wang F, Hewitt MC, Barberich TJ",,598654.0,DTCT0023221,3114465,DTCC00604453,812625,36218,5.853871964321762,800,45485564,COC1CN(CCC1NC(=O)C2=CC(=C(C=C2OC)N)Cl)CC3CCCCC3(C4=CC(=CC=C4)O)O,COc1cc(N)c(Cl)cc1C(=O)NC1CCN(CC2CCCCC2(O)c2cccc(O)c2)CC1OC
CHEMBL584743,P46098,,OHGAQBAXUOYIOB-AVRWGWEMSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19700325.0,IC50,=,4900.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human recombinant 5-HT3 receptor expressed in HEK293 cells,,mu-Opioid/5-HT4 dual pharmacologically active agents-efforts towards an effective opioid analgesic with less GI and respiratory side effects (Part I).,Bioorg. Med. Chem. Lett.,2009.0,19.0,19.0,"Shao L, Wang F, Hewitt MC, Barberich TJ",,598654.0,DTCT0023221,3114454,DTCC00604451,1810259,36218,5.309803919971486,802,45485562,CN(CCNC(=O)C1=CC(=C(C=C1OC)N)Cl)CC2CCCCC2(C3=CC(=CC=C3)OC)O,COc1cccc(C2(O)CCCCC2CN(C)CCNC(=O)c2cc(Cl)c(N)cc2OC)c1
CHEMBL585567,P46098,,SOEFWQWHKHCTLH-YUXJLSHCSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19700325.0,IC50,=,18.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human recombinant 5-HT3 receptor expressed in HEK293 cells,,mu-Opioid/5-HT4 dual pharmacologically active agents-efforts towards an effective opioid analgesic with less GI and respiratory side effects (Part I).,Bioorg. Med. Chem. Lett.,2009.0,19.0,19.0,"Shao L, Wang F, Hewitt MC, Barberich TJ",,598654.0,DTCT0023221,3114463,DTCC00604574,393299,36218,7.7447274948966935,803,44626294,COC1CN(CCC1NC(=O)C2=CC(=C(C=C2OC)N)Cl)CC3CCCCC3(C4=CC(=CC=C4)O)O,COc1cc(N)c(Cl)cc1C(=O)NC1CCN(CC2CCCCC2(O)c2cccc(O)c2)CC1OC
CHEMBL585925,P46098,,SOEFWQWHKHCTLH-ZSKASMGYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19700325.0,IC50,=,390.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]granisetron from human recombinant 5-HT3 receptor expressed in HEK293 cells,,mu-Opioid/5-HT4 dual pharmacologically active agents-efforts towards an effective opioid analgesic with less GI and respiratory side effects (Part I).,Bioorg. Med. Chem. Lett.,2009.0,19.0,19.0,"Shao L, Wang F, Hewitt MC, Barberich TJ",,598654.0,DTCT0023221,3114461,DTCC00604524,1363220,36218,6.4089353929735005,804,45485624,COC1CN(CCC1NC(=O)C2=CC(=C(C=C2OC)N)Cl)CC3CCCCC3(C4=CC(=CC=C4)O)O,COc1cc(N)c(Cl)cc1C(=O)NC1CCN(CC2CCCCC2(O)c2cccc(O)c2)CC1OC
CHEMBL595449,P46098,,ILPANLYEJQKXKY-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,19646882.0,IC50,>,10000.0,NM,,,,,,,,,,,,,,Inhibition of 5HT3 receptor,,Novel delta opioid receptor agonists exhibit differential stimulation of signaling pathways.,Bioorg. Med. Chem.,2009.0,17.0,17.0,"Peng Y, Zhang Q, Arora S, Keenan SM, Kortagere S, Wannemacher KM, Howells RD, Welsh WJ",,601696.0,DTCT0023221,3163162,DTCC00612138,1136637,36541,5.0,806,11957735,CC(C)(C)C1=CC=C(C=C1)C2=NC(=NN2C3=CC(=CC=C3)O)CN(C)C,CN(C)Cc1nc(-c2ccc(C(C)(C)C)cc2)n(-c2cccc(O)c2)n1
CHEMBL597241,P46098,,XJNOJISWTROLSF-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20043678.0,IC50,=,484.0,NM,,cell_based,,,,,,,,,,,,Agonist activity at human 5HT3 receptor expressed in human skin epithelial cells assessed as stimulation of calcium flux by FLIPR assay,,"Discovery of 4-(5-methyloxazolo[4,5-b]pyridin-2-yl)-1,4-diazabicyclo[3.2.2]nonane (CP-810,123), a novel alpha 7 nicotinic acetylcholine receptor agonist for the treatment of cognitive disorders in schizophrenia: synthesis, SAR development, and in vivo efficacy in cognition models.",J. Med. Chem.,2010.0,53.0,3.0,"O'Donnell CJ, Rogers BN, Bronk BS, Bryce DK, Coe JW, Cook KK, Duplantier AJ, Evrard E, Hajós M, Hoffmann WE, Hurst RS, Maklad N, Mather RJ, McLean S, Nedza FM, O'Neill BT, Peng L, Qian W, Rottas MM, Sands SB, Schmidt AW, Shrikhande AV, Spracklin DK, Wong DF, Zhang A, Zhang L",,611801.0,DTCT0023221,3181593,DTCC00618948,910774,37429,6.315154638355588,810,10286136,C1CN2CCC1N(CC2)C3=NC4=C(O3)C=C(C=N4)Cl,Clc1cnc2nc(N3CCN4CCC3CC4)oc2c1
CHEMBL597241,P46098,,XJNOJISWTROLSF-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21919481.0,IC50,=,484.0,NM,,,,,,,,,,,,,,Inhibition of 5HT3 receptor,,Discovery and development of a7 nicotinic acetylcholine receptor modulators.,J. Med. Chem.,2011.0,54.0,23.0,"Mazurov AA, Speake JD, Yohannes D",,851149.0,DTCT0023221,11361553,DTCC00618948,931901,50968,6.315154638355588,810,10286136,C1CN2CCC1N(CC2)C3=NC4=C(O3)C=C(C=N4)Cl,Clc1cnc2nc(N3CCN4CCC3CC4)oc2c1
CHEMBL597440,P46098,,ZLUOOMMZUAJVNO-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20043678.0,IC50,=,2480.0,NM,,cell_based,,,,,,,,,,,,Agonist activity at human 5HT3 receptor expressed in human skin epithelial cells assessed as stimulation of calcium flux by FLIPR assay,,"Discovery of 4-(5-methyloxazolo[4,5-b]pyridin-2-yl)-1,4-diazabicyclo[3.2.2]nonane (CP-810,123), a novel alpha 7 nicotinic acetylcholine receptor agonist for the treatment of cognitive disorders in schizophrenia: synthesis, SAR development, and in vivo efficacy in cognition models.",J. Med. Chem.,2010.0,53.0,3.0,"O'Donnell CJ, Rogers BN, Bronk BS, Bryce DK, Coe JW, Cook KK, Duplantier AJ, Evrard E, Hajós M, Hoffmann WE, Hurst RS, Maklad N, Mather RJ, McLean S, Nedza FM, O'Neill BT, Peng L, Qian W, Rottas MM, Sands SB, Schmidt AW, Shrikhande AV, Spracklin DK, Wong DF, Zhang A, Zhang L",,611801.0,DTCT0023221,3181594,DTCC00618949,1395715,37429,5.605548319173784,812,46180744,C1CN2CCC1N(CC2)C3=NC4=C(O3)C=C(C=N4)F,Fc1cnc2nc(N3CCN4CCC3CC4)oc2c1
CHEMBL597737,P46098,,ATCMRGMIYIPJQT-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20043678.0,IC50,>,7310.0,NM,,cell_based,,,,,,,,,,,,Agonist activity at human 5HT3 receptor expressed in human skin epithelial cells assessed as stimulation of calcium flux by FLIPR assay,,"Discovery of 4-(5-methyloxazolo[4,5-b]pyridin-2-yl)-1,4-diazabicyclo[3.2.2]nonane (CP-810,123), a novel alpha 7 nicotinic acetylcholine receptor agonist for the treatment of cognitive disorders in schizophrenia: synthesis, SAR development, and in vivo efficacy in cognition models.",J. Med. Chem.,2010.0,53.0,3.0,"O'Donnell CJ, Rogers BN, Bronk BS, Bryce DK, Coe JW, Cook KK, Duplantier AJ, Evrard E, Hajós M, Hoffmann WE, Hurst RS, Maklad N, Mather RJ, McLean S, Nedza FM, O'Neill BT, Peng L, Qian W, Rottas MM, Sands SB, Schmidt AW, Shrikhande AV, Spracklin DK, Wong DF, Zhang A, Zhang L",,611801.0,DTCT0023221,3181600,DTCC00618115,1842781,37429,5.13608262304214,813,11609760,C1CN2CCC1N(CC2)C3=NC4=C(O3)C=CC(=N4)C5=CC=CC=C5F,Fc1ccccc1-c1ccc2oc(N3CCN4CCC3CC4)nc2n1
CHEMBL603052,P46098,,PKPRDSSAMMLSLJ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20043678.0,IC50,=,70.0,NM,,cell_based,,,,,,,,,,,,Agonist activity at human 5HT3 receptor expressed in human skin epithelial cells assessed as stimulation of calcium flux by FLIPR assay,,"Discovery of 4-(5-methyloxazolo[4,5-b]pyridin-2-yl)-1,4-diazabicyclo[3.2.2]nonane (CP-810,123), a novel alpha 7 nicotinic acetylcholine receptor agonist for the treatment of cognitive disorders in schizophrenia: synthesis, SAR development, and in vivo efficacy in cognition models.",J. Med. Chem.,2010.0,53.0,3.0,"O'Donnell CJ, Rogers BN, Bronk BS, Bryce DK, Coe JW, Cook KK, Duplantier AJ, Evrard E, Hajós M, Hoffmann WE, Hurst RS, Maklad N, Mather RJ, McLean S, Nedza FM, O'Neill BT, Peng L, Qian W, Rottas MM, Sands SB, Schmidt AW, Shrikhande AV, Spracklin DK, Wong DF, Zhang A, Zhang L",,611801.0,DTCT0023221,3181598,DTCC00618110,878089,37429,7.154901959985743,825,11709098,CC1=C(C=C2C(=N1)N=C(O2)N3CCN4CCC3CC4)Cl,Cc1nc2nc(N3CCN4CCC3CC4)oc2cc1Cl
CHEMBL603052,P46098,,PKPRDSSAMMLSLJ-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,21919481.0,IC50,=,70.0,NM,,,,,,,,,,,,,,Inhibition of 5HT3 receptor,,Discovery and development of a7 nicotinic acetylcholine receptor modulators.,J. Med. Chem.,2011.0,54.0,23.0,"Mazurov AA, Speake JD, Yohannes D",,851149.0,DTCT0023221,11361559,DTCC00618110,900077,50968,7.154901959985743,825,11709098,CC1=C(C=C2C(=N1)N=C(O2)N3CCN4CCC3CC4)Cl,Cc1nc2nc(N3CCN4CCC3CC4)oc2cc1Cl
CHEMBL604798,P46098,CP-810123,BSNKYWSMUAGMDO-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20043678.0,IC50,=,5.0,NM,,cell_based,,,,,,,,,,,,Agonist activity at human 5HT3 receptor expressed in human skin epithelial cells assessed as stimulation of calcium flux by FLIPR assay,,"Discovery of 4-(5-methyloxazolo[4,5-b]pyridin-2-yl)-1,4-diazabicyclo[3.2.2]nonane (CP-810,123), a novel alpha 7 nicotinic acetylcholine receptor agonist for the treatment of cognitive disorders in schizophrenia: synthesis, SAR development, and in vivo efficacy in cognition models.",J. Med. Chem.,2010.0,53.0,3.0,"O'Donnell CJ, Rogers BN, Bronk BS, Bryce DK, Coe JW, Cook KK, Duplantier AJ, Evrard E, Hajós M, Hoffmann WE, Hurst RS, Maklad N, Mather RJ, McLean S, Nedza FM, O'Neill BT, Peng L, Qian W, Rottas MM, Sands SB, Schmidt AW, Shrikhande AV, Spracklin DK, Wong DF, Zhang A, Zhang L",,611801.0,DTCT0023221,3181595,DTCC00030113,1039298,37429,8.301029995663981,828,11184481,CC1=NC2=C(C=C1)OC(=N2)N3CCN4CCC3CC4,Cc1ccc2oc(N3CCN4CCC3CC4)nc2n1
CHEMBL611369,P46098,,MJSSERWIBBMXQD-UHFFFAOYSA-N,0,SEROTONIN 3A (5-HT3A) RECEPTOR,HTR3A,Ion channel,,,20043678.0,IC50,=,779.0,NM,,cell_based,,,,,,,,,,,,Agonist activity at human 5HT3 receptor expressed in human skin epithelial cells assessed as stimulation of calcium flux by FLIPR assay,,"Discovery of 4-(5-methyloxazolo[4,5-b]pyridin-2-yl)-1,4-diazabicyclo[3.2.2]nonane (CP-810,123), a novel alpha 7 nicotinic acetylcholine receptor agonist for the treatment of cognitive disorders in schizophrenia: synthesis, SAR development, and in vivo efficacy in cognition models.",J. Med. Chem.,2010.0,53.0,3.0,"O'Donnell CJ, Rogers BN, Bronk BS, Bryce DK, Coe JW, Cook KK, Duplantier AJ, Evrard E, Hajós M, Hoffmann WE, Hurst RS, Maklad N, Mather RJ, McLean S, Nedza FM, O'Neill BT, Peng L, Qian W, Rottas MM, Sands SB, Schmidt AW, Shrikhande AV, Spracklin DK, Wong DF, Zhang A, Zhang L",,611801.0,DTCT0023221,3181592,DTCC00124272,1167975,37429,6.108462542327436,832,11220991,C1CN2CCC1N(CC2)C3=NC4=C(O3)C=C(C=N4)Br,Brc1cnc2nc(N3CCN4CCC3CC4)oc2c1
